GOName,GOID,DiseaseName,DiseaseID,InferenceChemicalQty,InferenceChemicalNames,InferenceGeneQty,InferenceGeneSymbols
5-methylcytosine biosynthetic process,GO:0046082,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
acetate biosynthetic process,GO:0019413,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
acetylcholine biosynthetic process,GO:0008292,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
acetylcholine metabolic process,GO:0008291,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
acetylcholine secretion,GO:0061526,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Manganese,0,
acrosome reaction,GO:0007340,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Chlorpromazine,0,
actin cytoskeleton organization,GO:0030036,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
actin cytoskeleton organization,GO:0030036,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MRTFB
actin cytoskeleton organization,GO:0030036,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
actin cytoskeleton reorganization,GO:0031532,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
actin filament capping,GO:0051693,Child Behavior Disorders,MESH:D002653,1,Isoniazid,0,
actin filament depolymerization,GO:0030042,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
actin filament polymerization,GO:0030041,Child Behavior Disorders,MESH:D002653,1,methylmercuric chloride,0,
action potential initiation,GO:0099610,Child Behavior Disorders,MESH:D002653,3,Carbamazepine|Lamotrigine|Valproic Acid,0,
action potential initiation,GO:0099610,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
action potential initiation,GO:0099610,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
activation of adenylate cyclase activity,GO:0007190,Child Behavior Disorders,MESH:D002653,2,Lithium Carbonate|Manganese,0,
activation of adenylate cyclase activity,GO:0007190,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
activation of cysteine-type endopeptidase activity,GO:0097202,Child Behavior Disorders,MESH:D002653,2,Manganese|methylmercuric chloride,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,Child Behavior Disorders,MESH:D002653,3,Dextroamphetamine|Lead|Manganese,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,Child Nutrition Disorders,MESH:D015362,1,Mebendazole,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,GO:0008635,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
activation of immune response,GO:0002253,Child Behavior Disorders,MESH:D002653,1,Isoniazid,0,
activation of phospholipase C activity,GO:0007202,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
activation of protein kinase A activity,GO:0034199,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
activation of protein kinase A activity,GO:0034199,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
activation of protein kinase A activity,GO:0034199,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
activation of protein kinase B activity,GO:0032148,Child Behavior Disorders,MESH:D002653,3,bisphenol A|methylmercuric chloride|Phenobarbital,0,
activation of protein kinase B activity,GO:0032148,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
activation of protein kinase B activity,GO:0032148,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
activation of protein kinase C activity,GO:1990051,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
activation of protein kinase C activity,GO:1990051,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
acylglycerol metabolic process,GO:0006639,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
adenylate cyclase-activating adrenergic receptor signaling pathway,GO:0071880,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,DRD4
adenylate cyclase-activating adrenergic receptor signaling pathway,GO:0071880,"CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION",OMIM:616939,0,,1,GPR88
adenylate cyclase-inhibiting dopamine receptor signaling pathway,GO:0007195,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,DRD4
adenylate cyclase-modulating G protein-coupled receptor signaling pathway,GO:0007188,"CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION",OMIM:616939,0,,1,GPR88
adipose tissue development,GO:0060612,Child Behavior Disorders,MESH:D002653,5,bisphenol A|DDT|methylmercuric chloride|Olanzapine|Risperidone,0,
adipose tissue development,GO:0060612,"Child Development Disorders, Pervasive",MESH:D002659,1,Risperidone,0,
adipose tissue development,GO:0060612,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
adrenal gland development,GO:0030325,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
adrenergic receptor signaling pathway,GO:0071875,"CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION",OMIM:616939,0,,1,GPR88
adult behavior,GO:0030534,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Cocaine,0,
adult feeding behavior,GO:0008343,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
adult locomotory behavior,GO:0008344,Alternating hemiplegia of childhood,MESH:C536589,0,,2,ATP1A2|ATP1A3
adult locomotory behavior,GO:0008344,Child Behavior Disorders,MESH:D002653,4,bisphenol A|Cocaine|Dextromethorphan|Valproic Acid,0,
adult locomotory behavior,GO:0008344,"Child Development Disorders, Pervasive",MESH:D002659,2,Topiramate|Valproic Acid,2,DRD4|MECP2
adult walking behavior,GO:0007628,Child Behavior Disorders,MESH:D002653,1,Lead,0,
adult walking behavior,GO:0007628,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
aerobic electron transport chain,GO:0019646,Child Behavior Disorders,MESH:D002653,1,methylmercuric chloride,0,
aerobic respiration,GO:0009060,"Arthropathy, progressive pseudorheumatoid, of childhood",MESH:C535387,0,,1,CCN6
aerobic respiration,GO:0009060,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Lead|Valproic Acid,0,
aerobic respiration,GO:0009060,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
aerobic respiration,GO:0009060,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Ascorbic Acid|Lead,0,
aggrephagy,GO:0035973,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET",OMIM:617145,0,,1,SQSTM1
aggressive behavior,GO:0002118,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
aggressive behavior,GO:0002118,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
agmatine biosynthetic process,GO:0097055,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
alanine biosynthetic process,GO:0006523,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
allantois development,GO:1905069,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
alpha-tubulin acetylation,GO:0071929,Child Behavior Disorders,MESH:D002653,1,Niacinamide,0,
amine metabolic process,GO:0009308,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
amine metabolic process,GO:0009308,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
amino-acid betaine metabolic process,GO:0006577,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
amino acid biosynthetic process,GO:0008652,Child Behavior Disorders,MESH:D002653,3,bisphenol A|methylmercuric chloride|Valproic Acid,0,
amino acid biosynthetic process,GO:0008652,"Child Development Disorders, Pervasive",MESH:D002659,2,Methionine|Valproic Acid,0,
amino acid export across plasma membrane,GO:0032973,Child Nutrition Disorders,MESH:D015362,1,Cholecalciferol,0,
amino acid metabolic process,GO:0006520,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
amino acid metabolic process,GO:0006520,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
amino acid transport,GO:0006865,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
ammonium excretion,GO:0140734,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
ammonium homeostasis,GO:0097272,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
AMP catabolic process,GO:0006196,Child Behavior Disorders,MESH:D002653,1,Haloperidol,0,
amygdala development,GO:0021764,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A2
anatomical structure development,GO:0048856,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
anatomical structure development,GO:0048856,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
anatomical structure regression,GO:0060033,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
androgen biosynthetic process,GO:0006702,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
androgen biosynthetic process,GO:0006702,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
androgen catabolic process,GO:0006710,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
androgen metabolic process,GO:0008209,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
androgen metabolic process,GO:0008209,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
androgen receptor signaling pathway,GO:0030521,Child Behavior Disorders,MESH:D002653,1,Pentachlorophenol,0,
"androst-4-ene-3,17-dione biosynthetic process",GO:1903449,Child Behavior Disorders,MESH:D002653,3,Chlorpromazine|Haloperidol|Risperidone,0,
"androst-4-ene-3,17-dione biosynthetic process",GO:1903449,"Child Development Disorders, Pervasive",MESH:D002659,1,Risperidone,0,
"androst-4-ene-3,17-dione biosynthetic process",GO:1903449,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
angiogenesis,GO:0001525,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
angiogenesis,GO:0001525,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
angiogenesis,GO:0001525,Sick Building Syndrome,MESH:D018877,0,,1,PNPLA6
animal organ morphogenesis,GO:0009887,Child Behavior Disorders,MESH:D002653,1,Isoniazid,0,
animal organ morphogenesis,GO:0009887,"Myopathy, Reducing Body, X-Linked, Childhood-Onset",MESH:C567468,0,,1,FHL1
animal organ morphogenesis,GO:0009887,Sick Building Syndrome,MESH:D018877,0,,1,PNPLA6
anterior head development,GO:0097065,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
anterior/posterior axis specification,GO:0009948,Sick Building Syndrome,MESH:D018877,0,,1,PNPLA6
antibiotic metabolic process,GO:0016999,Child Behavior Disorders,MESH:D002653,1,Isoniazid,0,
antimicrobial humoral response,GO:0019730,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
antral ovarian follicle growth,GO:0001547,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
apical protein localization,GO:0045176,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
apical protein localization,GO:0045176,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
apoptotic chromosome condensation,GO:0030263,Child Behavior Disorders,MESH:D002653,6,bisphenol A|Lead|Lithium|Lithium Carbonate|Nitrogen Dioxide|Valproic Acid,0,
apoptotic chromosome condensation,GO:0030263,"Child Development Disorders, Pervasive",MESH:D002659,2,Topiramate|Valproic Acid,0,
apoptotic chromosome condensation,GO:0030263,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
apoptotic DNA fragmentation,GO:0006309,Child Behavior Disorders,MESH:D002653,11,Cocaine|Haloperidol|Imipramine|Isoniazid|Lithium|Methadone|methylmercuric chloride|Phenobarbital|Prednisolone|Theophylline|Valproic Acid,0,
apoptotic DNA fragmentation,GO:0006309,"Child Development Disorders, Pervasive",MESH:D002659,3,Citalopram|Methionine|Valproic Acid,0,
apoptotic DNA fragmentation,GO:0006309,Child Nutrition Disorders,MESH:D015362,2,Riboflavin|Vitamin A,0,
apoptotic DNA fragmentation,GO:0006309,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
apoptotic nuclear changes,GO:0030262,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
apoptotic process,GO:0006915,Child Behavior Disorders,MESH:D002653,23,Amphetamine|bisphenol A|Chlorpromazine|Cocaine|Cyproheptadine|DDT|Haloperidol|Imipramine|Isoniazid|Lead|Lithium|Manganese|Methadone|methylmercuric chloride|Methylphenidate|Niacinamide|Nitrogen Dioxide|Olanzapine|Pentachlorophenol|Phenobarbital|Prednisolone|Theophylline|Valproic Acid,0,
apoptotic process,GO:0006915,"Child Development Disorders, Pervasive",MESH:D002659,5,Aripiprazole|Citalopram|Methionine|Methylphenidate|Valproic Acid,0,
apoptotic process,GO:0006915,Child Nutrition Disorders,MESH:D015362,5,Cholecalciferol|Mebendazole|Riboflavin|Thiamine|Vitamin A,0,
apoptotic process,GO:0006915,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
apoptotic process,GO:0006915,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
apoptotic process,GO:0006915,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET",OMIM:617145,0,,1,SQSTM1
apoptotic process,GO:0006915,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
arachidonic acid metabolic process,GO:0019369,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
arachidonic acid secretion,GO:0050482,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,DRD4
arginine biosynthetic process,GO:0006526,Child Behavior Disorders,MESH:D002653,1,DDT,0,
arginine metabolic process,GO:0006525,Child Behavior Disorders,MESH:D002653,1,Nitrogen Dioxide,0,
asparagine biosynthetic process,GO:0006529,Child Behavior Disorders,MESH:D002653,2,DDT|Phenobarbital,0,
aspartate biosynthetic process,GO:0006532,Child Behavior Disorders,MESH:D002653,1,DDT,0,
aspartate metabolic process,GO:0006531,Child Behavior Disorders,MESH:D002653,1,Nitrogen Dioxide,0,
associative learning,GO:0008306,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
associative learning,GO:0008306,"Child Development Disorders, Pervasive",MESH:D002659,0,,2,DRD4|MECP2
astral microtubule nucleation,GO:0030954,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
astrocyte activation,GO:0048143,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
astrocyte activation,GO:0048143,Child Nutrition Disorders,MESH:D015362,1,Cholecalciferol,0,
astrocyte activation,GO:0048143,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
astrocyte activation involved in immune response,GO:0002265,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
astrocyte development,GO:0014002,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
astrocyte development,GO:0014002,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
ATP biosynthetic process,GO:0006754,Child Behavior Disorders,MESH:D002653,10,bisphenol A|Chlorpromazine|Haloperidol|Isoniazid|Lead|Lithium Carbonate|Niacinamide|Risperidone|Thioridazine|Valproic Acid,0,
ATP biosynthetic process,GO:0006754,"Child Development Disorders, Pervasive",MESH:D002659,2,Risperidone|Valproic Acid,0,
ATP biosynthetic process,GO:0006754,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
ATP biosynthetic process,GO:0006754,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
ATP biosynthetic process,GO:0006754,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
ATP generation from ADP,GO:0006757,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
ATP metabolic process,GO:0046034,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A2
ATP metabolic process,GO:0046034,Child Behavior Disorders,MESH:D002653,11,bisphenol A|Chlorpromazine|DDT|Dextroamphetamine|Lead|Manganese|methylmercuric chloride|Niacinamide|Nitrogen Dioxide|Phenobarbital|Valproic Acid,0,
ATP metabolic process,GO:0046034,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
ATP metabolic process,GO:0046034,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
attachment of mitotic spindle microtubules to kinetochore,GO:0051315,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
attachment of spindle microtubules to kinetochore,GO:0008608,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
autophagosome assembly,GO:0000045,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Pentachlorophenol,0,
autophagosome assembly,GO:0000045,Child Nutrition Disorders,MESH:D015362,1,Riboflavin,0,
autophagosome membrane disassembly,GO:0030399,Child Behavior Disorders,MESH:D002653,1,methylmercuric chloride,0,
autophagosome organization,GO:1905037,Child Behavior Disorders,MESH:D002653,1,Lead,0,
autophagosome organization,GO:1905037,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
autophagy,GO:0006914,Child Behavior Disorders,MESH:D002653,4,bisphenol A|Cocaine|Lithium|Manganese,0,
autophagy,GO:0006914,Child Nutrition Disorders,MESH:D015362,1,Cholecalciferol,0,
autophagy,GO:0006914,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
autophagy,GO:0006914,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET",OMIM:617145,0,,1,SQSTM1
autophagy of mitochondrion,GO:0000422,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
autophagy of mitochondrion,GO:0000422,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET",OMIM:617145,0,,1,SQSTM1
axon arborization,GO:0140060,Spinal Muscular Atrophies of Childhood,MESH:D014897,0,,1,SMN1
axon development,GO:0061564,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
axon development,GO:0061564,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
axon development,GO:0061564,Spinal Muscular Atrophies of Childhood,MESH:D014897,0,,1,SMN1
axon extension,GO:0048675,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
axon extension,GO:0048675,Spinal Muscular Atrophies of Childhood,MESH:D014897,0,,1,SMN1
axon guidance,GO:0007411,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
axonogenesis,GO:0007409,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Lead|methylmercuric chloride,0,
axonogenesis,GO:0007409,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
axonogenesis,GO:0007409,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET",OMIM:617145,0,,1,SQSTM1
axonogenesis,GO:0007409,Sick Building Syndrome,MESH:D018877,0,,1,PNPLA6
axonogenesis,GO:0007409,Spinal Muscular Atrophies of Childhood,MESH:D014897,0,,1,SMN1
axonogenesis involved in innervation,GO:0060385,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
baculum development,GO:1990375,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
base-excision repair,GO:0006284,Diffuse Cerebral Sclerosis of Schilder,MESH:D002549,0,,1,POLG
"base-excision repair, gap-filling",GO:0006287,Diffuse Cerebral Sclerosis of Schilder,MESH:D002549,0,,1,POLG
basophil chemotaxis,GO:0002575,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
B cell homeostasis,GO:0001782,Child Behavior Disorders,MESH:D002653,1,Nitrogen Dioxide,0,
behavior,GO:0007610,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
behavior,GO:0007610,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Lead|Manganese,0,
behavior,GO:0007610,"Child Development Disorders, Pervasive",MESH:D002659,1,Topiramate,0,
behavior,GO:0007610,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
behavioral defense response,GO:0002209,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
behavioral fear response,GO:0001662,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A2
behavioral fear response,GO:0001662,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Cocaine|methylmercuric chloride,0,
behavioral fear response,GO:0001662,"Child Development Disorders, Pervasive",MESH:D002659,1,Citalopram,2,DRD4|MECP2
behavioral response to chemical pain,GO:0061366,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
behavioral response to cocaine,GO:0048148,Child Behavior Disorders,MESH:D002653,1,Cocaine,0,
behavioral response to cocaine,GO:0048148,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,DRD4
behavioral response to ethanol,GO:0048149,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,DRD4
behavioral response to ethanol,GO:0048149,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
behavioral response to nicotine,GO:0035095,Child Behavior Disorders,MESH:D002653,1,Cocaine,0,
behavioral response to pain,GO:0048266,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
behavioral response to pain,GO:0048266,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
behavioral response to pain,GO:0048266,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
behavioral response to water deprivation,GO:0042630,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
benzoate transport,GO:0042919,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
benzoate transport,GO:0042919,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
beta-alanine metabolic process,GO:0019482,Child Behavior Disorders,MESH:D002653,1,Nitrogen Dioxide,0,
bile acid and bile salt transport,GO:0015721,Child Behavior Disorders,MESH:D002653,1,Chlorpromazine,0,
bile acid biosynthetic process,GO:0006699,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
bile acid catabolic process,GO:0030573,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
bile acid metabolic process,GO:0008206,Child Behavior Disorders,MESH:D002653,5,bisphenol A|Isoniazid|Lead|Manganese|Phenobarbital,0,
bile acid metabolic process,GO:0008206,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
bile acid metabolic process,GO:0008206,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
bile acid secretion,GO:0032782,Child Behavior Disorders,MESH:D002653,1,Chlorpromazine,0,
bilirubin transport,GO:0015723,Child Behavior Disorders,MESH:D002653,2,Isoniazid|Prednisolone,0,
bilirubin transport,GO:0015723,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
binding of sperm to zona pellucida,GO:0007339,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
biogenic amine metabolic process,GO:0006576,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
biogenic amine metabolic process,GO:0006576,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
biological_process,GO:0008150,"Arthropathy, progressive pseudorheumatoid, of childhood",MESH:C535387,0,,1,CCN6
biological_process,GO:0008150,"HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT",OMIM:617384,0,,1,DNAJC12
biomineral tissue development,GO:0031214,"Hypophosphatasia, Childhood",MESH:C562440,0,,1,ALPL
blastocyst development,GO:0001824,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Isoniazid,0,
blastocyst formation,GO:0001825,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
blood circulation,GO:0008015,Alternating hemiplegia of childhood,MESH:C536589,0,,2,ATP1A2|ATP1A3
blood circulation,GO:0008015,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Haloperidol,0,
blood coagulation,GO:0007596,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
"blood coagulation, fibrin clot formation",GO:0072378,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
blood vessel diameter maintenance,GO:0097746,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
blood vessel morphogenesis,GO:0048514,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MRTFB
BMP signaling pathway,GO:0030509,"Arthropathy, progressive pseudorheumatoid, of childhood",MESH:C535387,0,,1,CCN6
bone development,GO:0060348,Child Behavior Disorders,MESH:D002653,4,bisphenol A|Lead|Nitrogen Dioxide|Prednisolone,0,
bone development,GO:0060348,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
bone development,GO:0060348,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
bone growth,GO:0098868,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
bone maturation,GO:0070977,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
bone mineralization,GO:0030282,Child Behavior Disorders,MESH:D002653,4,bisphenol A|Lead|Prednisolone|Prednisone,0,
bone mineralization,GO:0030282,"Hypophosphatasia, Childhood",MESH:C562440,0,,1,ALPL
bone mineralization,GO:0030282,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Ascorbic Acid|Lead,0,
bone regeneration,GO:1990523,Child Behavior Disorders,MESH:D002653,1,Theophylline,0,
brain-derived neurotrophic factor receptor signaling pathway,GO:0031547,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
brain-derived neurotrophic factor receptor signaling pathway,GO:0031547,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
brain development,GO:0007420,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
brain development,GO:0007420,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
brain development,GO:0007420,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
brain morphogenesis,GO:0048854,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
branching involved in mammary gland duct morphogenesis,GO:0060444,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
brown fat cell proliferation,GO:0070342,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET",OMIM:617145,0,,1,SQSTM1
C21-steroid hormone metabolic process,GO:0008207,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
C-5 methylation of cytosine,GO:0090116,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
C-5 methylation of cytosine,GO:0090116,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
calcitriol biosynthetic process from calciol,GO:0036378,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
calcium import into the mitochondrion,GO:0036444,Child Behavior Disorders,MESH:D002653,4,Dextroamphetamine|Lead|Lithium|Valproic Acid,0,
calcium import into the mitochondrion,GO:0036444,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
calcium import into the mitochondrion,GO:0036444,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
calcium ion export,GO:1901660,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
calcium ion homeostasis,GO:0055074,Child Behavior Disorders,MESH:D002653,7,bisphenol A|Chlorpromazine|Isoniazid|Lead|Lithium|Theophylline|Valproic Acid,0,
calcium ion homeostasis,GO:0055074,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
calcium ion homeostasis,GO:0055074,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,1,KL
calcium ion homeostasis,GO:0055074,"Hypophosphatasia, Childhood",MESH:C562440,0,,1,ALPL
calcium ion homeostasis,GO:0055074,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
calcium ion import,GO:0070509,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Manganese,0,
calcium ion import across plasma membrane,GO:0098703,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
calcium ion transport,GO:0006816,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Dextroamphetamine,0,
calcium ion transport from cytosol to endoplasmic reticulum,GO:1903515,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
calcium-mediated signaling,GO:0019722,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
calcium-mediated signaling,GO:0019722,Child Behavior Disorders,MESH:D002653,1,Risperidone,0,
calcium-mediated signaling,GO:0019722,"Child Development Disorders, Pervasive",MESH:D002659,2,Risperidone|Topiramate,0,
camera-type eye photoreceptor cell differentiation,GO:0060219,Spinal Muscular Atrophies of Childhood,MESH:D014897,0,,1,DYNC1H1
cAMP biosynthetic process,GO:0006171,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Manganese|Methadone,0,
cAMP biosynthetic process,GO:0006171,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
cAMP catabolic process,GO:0006198,Child Behavior Disorders,MESH:D002653,1,Theophylline,0,
carbohydrate metabolic process,GO:0005975,Child Behavior Disorders,MESH:D002653,2,bisphenol A|methylmercuric chloride,0,
carbohydrate metabolic process,GO:0005975,"Hypercalciuria, childhood idiopathic",MESH:C536082,0,,1,KL
carbohydrate metabolic process,GO:0005975,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
carboxylic acid metabolic process,GO:0019752,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
carboxylic acid transport,GO:0046942,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
cardiac chamber ballooning,GO:0003242,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cardiac fibroblast cell differentiation,GO:0060935,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cardiac muscle cell contraction,GO:0086003,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Haloperidol,0,
cardiac muscle cell differentiation,GO:0055007,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
cardiac muscle cell differentiation,GO:0055007,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
cardiac muscle cell differentiation,GO:0055007,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
cardiac muscle contraction,GO:0060048,Alternating hemiplegia of childhood,MESH:C536589,0,,2,ATP1A2|ATP1A3
cardiac muscle contraction,GO:0060048,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Theophylline,0,
cardiac muscle hypertrophy,GO:0003300,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cardiac muscle tissue development,GO:0048738,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MRTFB
cardiac muscle tissue morphogenesis,GO:0055008,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cardiolipin metabolic process,GO:0032048,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
carnitine biosynthetic process,GO:0045329,Child Behavior Disorders,MESH:D002653,1,Olanzapine,0,
carnitine metabolic process,GO:0009437,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
carnitine metabolic process,GO:0009437,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
carnitine transmembrane transport,GO:1902603,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
carnitine transport,GO:0015879,Child Behavior Disorders,MESH:D002653,1,Olanzapine,0,
cartilage condensation,GO:0001502,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
cartilage development,GO:0051216,"Arthropathy, progressive pseudorheumatoid, of childhood",MESH:C535387,0,,1,CCN6
cartilage development,GO:0051216,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Valproic Acid,0,
cartilage development,GO:0051216,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
cartilage development,GO:0051216,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
cartilage development involved in endochondral bone morphogenesis,GO:0060351,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
cartilage homeostasis,GO:1990079,Child Behavior Disorders,MESH:D002653,1,Lead,0,
cartilage homeostasis,GO:1990079,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
cartilage morphogenesis,GO:0060536,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
catecholamine secretion,GO:0050432,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
"CD4-positive, alpha-beta intraepithelial T cell differentiation",GO:0002301,Child Behavior Disorders,MESH:D002653,1,Lead,0,
"CD4-positive, alpha-beta intraepithelial T cell differentiation",GO:0002301,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
"CD4-positive, alpha-beta T cell cytokine production",GO:0035743,Child Behavior Disorders,MESH:D002653,1,Carbamazepine,0,
"CD8-positive, alpha-beta T cell differentiation",GO:0043374,Child Behavior Disorders,MESH:D002653,1,Lead,0,
"CD8-positive, alpha-beta T cell differentiation",GO:0043374,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
cell-abiotic substrate adhesion,GO:0036164,Child Behavior Disorders,MESH:D002653,2,bisphenol A|methylmercuric chloride,0,
cell adhesion,GO:0007155,"Arthropathy, progressive pseudorheumatoid, of childhood",MESH:C535387,0,,1,CCN6
cell adhesion,GO:0007155,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cell adhesion involved in heart morphogenesis,GO:0061343,"HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT",OMIM:617384,0,,1,DNAJC12
cell aggregation,GO:0098743,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Chlorpromazine|methylmercuric chloride,0,
cell aggregation,GO:0098743,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
cell-cell adhesion,GO:0098609,Child Behavior Disorders,MESH:D002653,2,bisphenol A|DDT,0,
cell-cell adhesion in response to extracellular stimulus,GO:0140039,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cell-cell fusion,GO:0140253,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Valproic Acid,0,
cell-cell fusion,GO:0140253,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
cell-cell junction organization,GO:0045216,Child Behavior Disorders,MESH:D002653,1,Lead,0,
cell-cell junction organization,GO:0045216,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
cell-cell signaling,GO:0007267,"Arthropathy, progressive pseudorheumatoid, of childhood",MESH:C535387,0,,1,CCN6
cell-cell signaling,GO:0007267,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cell chemotaxis,GO:0060326,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Carbon|Valproic Acid,0,
cell chemotaxis,GO:0060326,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
cell chemotaxis,GO:0060326,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
cell communication by electrical coupling involved in cardiac conduction,GO:0086064,Alternating hemiplegia of childhood,MESH:C536589,0,,2,ATP1A2|ATP1A3
cell cycle,GO:0007049,Child Behavior Disorders,MESH:D002653,5,bisphenol A|Cocaine|Lithium|Prednisolone|Valproic Acid,0,
cell cycle,GO:0007049,"Child Development Disorders, Pervasive",MESH:D002659,2,Methionine|Valproic Acid,0,
cell cycle,GO:0007049,Child Nutrition Disorders,MESH:D015362,3,Cholecalciferol|Riboflavin|Vitamin A,0,
cell cycle,GO:0007049,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
cell death,GO:0008219,Child Behavior Disorders,MESH:D002653,20,bisphenol A|Carbamazepine|Chlorpromazine|Cocaine|DDT|Dextromethorphan|Haloperidol|Imipramine|Isoniazid|Lead|Lithium|Manganese|Methadone|methylmercuric chloride|Nitrogen Dioxide|Pentachlorophenol|Phenobarbital|Pyridoxine|Theophylline|Valproic Acid,0,
cell death,GO:0008219,"Child Development Disorders, Pervasive",MESH:D002659,3,Methionine|Topiramate|Valproic Acid,0,
cell death,GO:0008219,Child Nutrition Disorders,MESH:D015362,2,Pyridoxine|Vitamin A,0,
cell death,GO:0008219,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
cell death,GO:0008219,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
cell death,GO:0008219,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
cell differentiation,GO:0030154,Child Behavior Disorders,MESH:D002653,5,bisphenol A|Cocaine|Lead|Lithium|Valproic Acid,0,
cell differentiation,GO:0030154,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
cell differentiation,GO:0030154,Child Nutrition Disorders,MESH:D015362,2,Cholecalciferol|Vitamin A,0,
cell differentiation,GO:0030154,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
cell differentiation,GO:0030154,"Myopathy, Reducing Body, X-Linked, Childhood-Onset",MESH:C567468,0,,1,FHL1
cell differentiation,GO:0030154,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET",OMIM:617145,0,,1,SQSTM1
cell differentiation,GO:0030154,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
cell division,GO:0051301,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cell division,GO:0051301,Spinal Muscular Atrophies of Childhood,MESH:D014897,0,,1,DYNC1H1
cell growth,GO:0016049,Child Behavior Disorders,MESH:D002653,8,bisphenol A|Carbamazepine|Chlorpromazine|Cocaine|Isoniazid|Lead|methylmercuric chloride|Valproic Acid,0,
cell growth,GO:0016049,"Child Development Disorders, Pervasive",MESH:D002659,2,Methionine|Valproic Acid,0,
cell growth,GO:0016049,Child Nutrition Disorders,MESH:D015362,1,Mebendazole,0,
cell growth,GO:0016049,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
cell growth,GO:0016049,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
cell-matrix adhesion,GO:0007160,Child Behavior Disorders,MESH:D002653,1,DDT,0,
cell migration,GO:0016477,Child Behavior Disorders,MESH:D002653,4,bisphenol A|Carbamazepine|Isoniazid|Valproic Acid,0,
cell migration,GO:0016477,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
cell migration,GO:0016477,Child Nutrition Disorders,MESH:D015362,1,Mebendazole,0,
cell migration,GO:0016477,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
cell morphogenesis,GO:0000902,Child Behavior Disorders,MESH:D002653,1,Lead,0,
cell morphogenesis,GO:0000902,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
cell motility,GO:0048870,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cell population proliferation,GO:0008283,Child Behavior Disorders,MESH:D002653,19,Adrenal Cortex Hormones|Amphetamine|bisphenol A|Chlorpromazine|Cocaine|Cyproheptadine|DDT|Imipramine|Lead|Lithium|Manganese|methylmercuric chloride|Niacinamide|Olanzapine|Pentachlorophenol|Phenobarbital|Prednisolone|Theophylline|Valproic Acid,0,
cell population proliferation,GO:0008283,"Child Development Disorders, Pervasive",MESH:D002659,4,Citalopram|Methionine|Topiramate|Valproic Acid,1,MECP2
cell population proliferation,GO:0008283,Child Nutrition Disorders,MESH:D015362,5,Cholecalciferol|Mebendazole|Riboflavin|Thiamine|Vitamin A,0,
cell population proliferation,GO:0008283,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
cell population proliferation,GO:0008283,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
cell population proliferation,GO:0008283,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
cell projection morphogenesis,GO:0048858,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cell projection organization,GO:0030030,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cell proliferation in bone marrow,GO:0071838,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cell quiescence,GO:0044838,Child Behavior Disorders,MESH:D002653,1,Lead,0,
cell quiescence,GO:0044838,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
cell redox homeostasis,GO:0045454,Child Behavior Disorders,MESH:D002653,4,bisphenol A|Lithium Carbonate|Niacinamide|Prednisolone,0,
cell redox homeostasis,GO:0045454,Child Nutrition Disorders,MESH:D015362,1,Vitamin A,0,
cell redox homeostasis,GO:0045454,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Ascorbic Acid|lead acetate,0,
cell-substrate adhesion,GO:0031589,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cell surface receptor signaling pathway,GO:0007166,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cellular aldehyde metabolic process,GO:0006081,Child Behavior Disorders,MESH:D002653,1,Chlorpromazine,0,
cellular amino acid homeostasis,GO:0080144,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cellular calcium ion homeostasis,GO:0006874,Child Behavior Disorders,MESH:D002653,10,Amphetamine|bisphenol A|Chlorpromazine|Dextromethorphan|Fluvoxamine|Imipramine|Lead|methylmercuric chloride|Theophylline|Valproic Acid,0,
cellular calcium ion homeostasis,GO:0006874,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,1,DRD4
cellular calcium ion homeostasis,GO:0006874,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
cellular calcium ion homeostasis,GO:0006874,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
cellular copper ion homeostasis,GO:0006878,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
cellular detoxification,GO:1990748,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cellular glucose homeostasis,GO:0001678,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
cellular glucose homeostasis,GO:0001678,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
cellular homeostasis,GO:0019725,"Hypophosphatasia, Childhood",MESH:C562440,0,,1,ALPL
cellular iron ion homeostasis,GO:0006879,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Lead|Valproic Acid,0,
cellular iron ion homeostasis,GO:0006879,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
cellular iron ion homeostasis,GO:0006879,"DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES",OMIM:617282,0,,1,MECR
cellular iron ion homeostasis,GO:0006879,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
cellular lipid catabolic process,GO:0044242,Child Nutrition Disorders,MESH:D015362,1,Vitamin A,0,
cellular lipid metabolic process,GO:0044255,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cellular metabolic process,GO:0044237,Child Behavior Disorders,MESH:D002653,14,bisphenol A|Chlorpromazine|Cyproheptadine|Fluvoxamine|Imipramine|Isoniazid|Lead|Lithium|Manganese|methylmercuric chloride|Methylphenidate|Pentachlorophenol|Pyridoxine|Valproic Acid,0,
cellular metabolic process,GO:0044237,"Child Development Disorders, Pervasive",MESH:D002659,3,Methionine|Methylphenidate|Valproic Acid,0,
cellular metabolic process,GO:0044237,Child Nutrition Disorders,MESH:D015362,2,Mebendazole|Pyridoxine,0,
cellular metabolic process,GO:0044237,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
cellular metabolic process,GO:0044237,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
cellular metal ion homeostasis,GO:0006875,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
cellular oxidant detoxification,GO:0098869,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
cellular potassium ion homeostasis,GO:0030007,Alternating hemiplegia of childhood,MESH:C536589,0,,2,ATP1A2|ATP1A3
cellular respiration,GO:0045333,Child Behavior Disorders,MESH:D002653,6,bisphenol A|Lead|Manganese|Methadone|methylmercuric chloride|Valproic Acid,0,
cellular respiration,GO:0045333,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
cellular respiration,GO:0045333,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
cellular respiration,GO:0045333,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Ascorbic Acid|Lead,0,
cellular respiration,GO:0045333,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
"cellular response to 3,3',5-triiodo-L-thyronine",GO:1905243,Spinal Muscular Atrophies of Childhood,MESH:D014897,0,,1,DYNC1H1
cellular response to amphetamine,GO:0071419,Child Behavior Disorders,MESH:D002653,1,Dextroamphetamine,0,
cellular response to amyloid-beta,GO:1904646,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
cellular response to antibiotic,GO:0071236,Child Behavior Disorders,MESH:D002653,1,Isoniazid,0,
cellular response to arsenite(3-),GO:1903841,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
cellular response to BMP stimulus,GO:0071773,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
cellular response to calcium ion,GO:0071277,Child Behavior Disorders,MESH:D002653,1,Lead,0,
cellular response to calcium ion,GO:0071277,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
cellular response to chemical stimulus,GO:0070887,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
cellular response to cocaine,GO:0071314,Child Behavior Disorders,MESH:D002653,1,Cocaine,0,
cellular response to DNA damage stimulus,GO:0006974,Child Behavior Disorders,MESH:D002653,10,bisphenol A|Cocaine|Isoniazid|Lead|Manganese|methylmercuric chloride|Niacinamide|Pentachlorophenol|Phenobarbital|Valproic Acid,0,
cellular response to DNA damage stimulus,GO:0006974,"Child Development Disorders, Pervasive",MESH:D002659,2,Methionine|Valproic Acid,0,
cellular response to DNA damage stimulus,GO:0006974,Child Nutrition Disorders,MESH:D015362,3,Cholecalciferol|Mebendazole|Thiamine,0,
cellular response to DNA damage stimulus,GO:0006974,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
cellular response to estrogen stimulus,GO:0071391,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cellular response to fluoride,GO:1902618,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cellular response to gamma radiation,GO:0071480,Child Behavior Disorders,MESH:D002653,1,Lead,0,
cellular response to gamma radiation,GO:0071480,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
cellular response to glucose stimulus,GO:0071333,Diffuse Cerebral Sclerosis of Schilder,MESH:D002549,0,,1,POLG
cellular response to heat,GO:0034605,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cellular response to high light intensity,GO:0071486,Child Behavior Disorders,MESH:D002653,1,Isoniazid,0,
cellular response to high light intensity,GO:0071486,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
cellular response to insulin-like growth factor stimulus,GO:1990314,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
cellular response to insulin stimulus,GO:0032869,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cellular response to isoquinoline alkaloid,GO:0071317,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
cellular response to lead ion,GO:0071284,Child Behavior Disorders,MESH:D002653,1,Lead,0,
cellular response to lead ion,GO:0071284,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
cellular response to light stimulus,GO:0071482,Child Behavior Disorders,MESH:D002653,1,Chlorpromazine,0,
cellular response to light stimulus,GO:0071482,"CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION",OMIM:616939,0,,1,GPR88
cellular response to mechanical stimulus,GO:0071260,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A2
cellular response to mechanical stimulus,GO:0071260,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
cellular response to mycotoxin,GO:0036146,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
cellular response to nerve growth factor stimulus,GO:1990090,Spinal Muscular Atrophies of Childhood,MESH:D014897,0,,1,DYNC1H1
cellular response to nicotine,GO:0071316,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
cellular response to nutrient levels,GO:0031669,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cellular response to oxidative stress,GO:0034599,Child Behavior Disorders,MESH:D002653,3,Carbamazepine|Lead|Nitrogen Dioxide,0,
cellular response to oxidative stress,GO:0034599,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
cellular response to parathyroid hormone stimulus,GO:0071374,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
cellular response to peptide hormone stimulus,GO:0071375,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
cellular response to potassium ion,GO:0035865,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
cellular response to redox state,GO:0071461,Child Behavior Disorders,MESH:D002653,1,Lead,0,
cellular response to redox state,GO:0071461,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
cellular response to retinoic acid,GO:0071300,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
cellular response to retinoic acid,GO:0071300,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
cellular response to steroid hormone stimulus,GO:0071383,Alternating hemiplegia of childhood,MESH:C536589,0,,2,ATP1A2|ATP1A3
cellular response to stress,GO:0033554,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET",OMIM:617145,0,,1,SQSTM1
cellular response to thyroid hormone stimulus,GO:0097067,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
cellular response to toxic substance,GO:0097237,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
cellular response to tumor necrosis factor,GO:0071356,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
cellular response to UV,GO:0034644,Child Behavior Disorders,MESH:D002653,1,Chlorpromazine,0,
cellular response to UV-A,GO:0071492,Child Nutrition Disorders,MESH:D015362,1,Riboflavin,0,
cellular response to UV-B,GO:0071493,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
cellular response to UV-B,GO:0071493,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
cellular response to UV-C,GO:0071494,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cellular response to vitamin E,GO:0071306,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
cellular response to xenobiotic stimulus,GO:0071466,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cellular response to xenobiotic stimulus,GO:0071466,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
cellular senescence,GO:0090398,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Niacinamide|Valproic Acid,0,
cellular senescence,GO:0090398,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
cellular senescence,GO:0090398,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
cellular sodium ion homeostasis,GO:0006883,Alternating hemiplegia of childhood,MESH:C536589,0,,2,ATP1A2|ATP1A3
cementum mineralization,GO:0071529,"Hypophosphatasia, Childhood",MESH:C562440,0,,1,ALPL
central nervous system development,GO:0007417,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
central nervous system myelination,GO:0022010,Child Behavior Disorders,MESH:D002653,1,Lead,0,
central nervous system myelination,GO:0022010,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
central nervous system myelination,GO:0022010,Spinal Muscular Atrophies of Childhood,MESH:D014897,0,,1,DYNC1H1
central nervous system myelin maintenance,GO:0032286,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
centriole replication,GO:0007099,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
centrosome duplication,GO:0051298,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
ceramide biosynthetic process,GO:0046513,"DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES",OMIM:617282,0,,1,MECR
ceramide metabolic process,GO:0006672,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cerebellum development,GO:0021549,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
cerebral cortex development,GO:0021987,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
cerebral cortex development,GO:0021987,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
cGMP biosynthetic process,GO:0006182,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cGMP metabolic process,GO:0046068,Child Nutrition Disorders,MESH:D015362,1,Thiamine,0,
changes to DNA methylation involved in embryo development,GO:1901538,Child Behavior Disorders,MESH:D002653,1,DDT,0,
chemical synaptic transmission,GO:0007268,Child Behavior Disorders,MESH:D002653,8,Amphetamine|Cocaine|Lead|Lithium|Methadone|Olanzapine|Phenobarbital|Risperidone,0,
chemical synaptic transmission,GO:0007268,"Child Development Disorders, Pervasive",MESH:D002659,1,Risperidone,1,MECP2
chemical synaptic transmission,GO:0007268,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
chemical synaptic transmission,GO:0007268,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
chemical synaptic transmission,GO:0007268,Spinal Muscular Atrophies of Childhood,MESH:D014897,0,,1,SMN1
chemosensory behavior,GO:0007635,Child Behavior Disorders,MESH:D002653,3,Carbamazepine|Cocaine|Valproic Acid,0,
chemosensory behavior,GO:0007635,"Child Development Disorders, Pervasive",MESH:D002659,2,Topiramate|Valproic Acid,0,
chemotaxis,GO:0006935,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
chemotaxis,GO:0006935,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
chloride transmembrane transport,GO:1902476,Child Behavior Disorders,MESH:D002653,2,methylmercuric chloride|Phenobarbital,0,
cholesterol biosynthetic process,GO:0006695,Child Behavior Disorders,MESH:D002653,4,bisphenol A|Dextromethorphan|Haloperidol|Isoniazid,0,
cholesterol biosynthetic process,GO:0006695,"Child Development Disorders, Pervasive",MESH:D002659,2,Aripiprazole|Methionine,0,
cholesterol biosynthetic process,GO:0006695,Child Nutrition Disorders,MESH:D015362,2,Cholecalciferol|Riboflavin,0,
cholesterol biosynthetic process,GO:0006695,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
cholesterol biosynthetic process,GO:0006695,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
cholesterol homeostasis,GO:0042632,Child Behavior Disorders,MESH:D002653,4,bisphenol A|Dextromethorphan|Manganese|Olanzapine,0,
cholesterol homeostasis,GO:0042632,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
cholesterol homeostasis,GO:0042632,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Ascorbic Acid|lead acetate,0,
cholesterol metabolic process,GO:0008203,Child Behavior Disorders,MESH:D002653,5,bisphenol A|Lamotrigine|Lead|Niacinamide|Valproic Acid,0,
cholesterol metabolic process,GO:0008203,"Child Development Disorders, Pervasive",MESH:D002659,2,Methionine|Valproic Acid,0,
cholesterol metabolic process,GO:0008203,Child Nutrition Disorders,MESH:D015362,2,Cholecalciferol|Vitamin A,0,
cholesterol metabolic process,GO:0008203,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
choline metabolic process,GO:0019695,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
choline metabolic process,GO:0019695,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
chondroblast differentiation,GO:0060591,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
chondrocyte differentiation,GO:0002062,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
chondrocyte differentiation,GO:0002062,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
chromatin organization,GO:0006325,Child Behavior Disorders,MESH:D002653,2,Lead|methylmercuric chloride,0,
chromatin organization,GO:0006325,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
chromatin remodeling,GO:0006338,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
chromosome localization,GO:0050000,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cilium movement,GO:0003341,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
cilium movement,GO:0003341,Spinal Muscular Atrophies of Childhood,MESH:D014897,0,,1,DYNC1H1
circadian regulation of gene expression,GO:0032922,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Valproic Acid,0,
circadian regulation of gene expression,GO:0032922,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
circadian rhythm,GO:0007623,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
circadian rhythm,GO:0007623,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
circadian rhythm,GO:0007623,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,DRD4
citrulline biosynthetic process,GO:0019240,Child Behavior Disorders,MESH:D002653,1,Phenobarbital,0,
cognition,GO:0050890,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
cognition,GO:0050890,Child Behavior Disorders,MESH:D002653,5,bisphenol A|DDT|Lead|Manganese|Nitrogen Dioxide,0,
cognition,GO:0050890,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
collagen biosynthetic process,GO:0032964,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Prednisolone,0,
collagen biosynthetic process,GO:0032964,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
collagen fibril organization,GO:0030199,Child Behavior Disorders,MESH:D002653,8,bisphenol A|Lead|Lithium|Lithium Carbonate|Phenobarbital|Prednisolone|Prednisone|Valproic Acid,0,
collagen fibril organization,GO:0030199,"Child Development Disorders, Pervasive",MESH:D002659,2,Methionine|Valproic Acid,0,
collagen fibril organization,GO:0030199,Child Nutrition Disorders,MESH:D015362,2,Cholecalciferol|Vitamin A,0,
collagen fibril organization,GO:0030199,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Ascorbic Acid|Lead,0,
collagen fibril organization,GO:0030199,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
conditioned place preference,GO:1990708,Child Behavior Disorders,MESH:D002653,1,Cocaine,0,
copper ion homeostasis,GO:0055070,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Manganese,0,
copper ion import across plasma membrane,GO:0098705,Child Behavior Disorders,MESH:D002653,1,Pentachlorophenol,0,
copper ion transport,GO:0006825,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
copulation,GO:0007620,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
corticosterone secretion,GO:0035934,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cortisol metabolic process,GO:0034650,Child Behavior Disorders,MESH:D002653,1,Lead,0,
cortisol metabolic process,GO:0034650,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
courtship behavior,GO:0007619,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cranial skeletal system development,GO:1904888,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Valproic Acid,0,
cranial skeletal system development,GO:1904888,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
creatine metabolic process,GO:0006600,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
creatine metabolic process,GO:0006600,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
creatinine catabolic process,GO:0006602,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
creatinine metabolic process,GO:0046449,Child Behavior Disorders,MESH:D002653,6,bisphenol A|Lead|Lithium Carbonate|methylmercuric chloride|Phenobarbital|Valproic Acid,0,
creatinine metabolic process,GO:0046449,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
creatinine metabolic process,GO:0046449,Child Nutrition Disorders,MESH:D015362,1,Cholecalciferol,0,
creatinine metabolic process,GO:0046449,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
cumulus cell differentiation,GO:0001549,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cysteine biosynthetic process,GO:0019344,Child Behavior Disorders,MESH:D002653,1,DDT,0,
cysteine metabolic process,GO:0006534,Child Behavior Disorders,MESH:D002653,1,methylmercuric chloride,0,
cytokine-mediated signaling pathway,GO:0019221,Child Behavior Disorders,MESH:D002653,1,Nitrogen Dioxide,0,
cytokine production involved in immune response,GO:0002367,Child Behavior Disorders,MESH:D002653,1,Nitrogen Dioxide,0,
cytokine production involved in inflammatory response,GO:0002534,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Lead|Manganese,0,
cytokine production involved in inflammatory response,GO:0002534,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
cytoplasmic sequestering of transcription factor,GO:0042994,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cytoplasm organization,GO:0007028,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
cytosine metabolic process,GO:0019858,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
decidualization,GO:0046697,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
decidualization,GO:0046697,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
defense response to bacterium,GO:0042742,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
defense response to bacterium,GO:0042742,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET",OMIM:617145,0,,1,SQSTM1
defense response to virus,GO:0051607,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
dendrite arborization,GO:0140059,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Valproic Acid,0,
dendrite arborization,GO:0140059,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
dendrite arborization,GO:0140059,Child Nutrition Disorders,MESH:D015362,1,Vitamin A,0,
dendrite development,GO:0016358,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
dendrite development,GO:0016358,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
dendrite development,GO:0016358,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
dendrite development,GO:0016358,Spinal Muscular Atrophies of Childhood,MESH:D014897,0,,1,SMN1
dendritic cell proliferation,GO:0044565,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
dendritic spine development,GO:0060996,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Lead|Lithium,0,
dendritic spine development,GO:0060996,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
dendritic spine maintenance,GO:0097062,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
dendritic spine maintenance,GO:0097062,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
dentate gyrus development,GO:0021542,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
dentate gyrus development,GO:0021542,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
deoxyguanosine biosynthetic process,GO:0042452,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
dephosphorylation,GO:0016311,"Hypophosphatasia, Childhood",MESH:C562440,0,,1,ALPL
detection of mechanical stimulus involved in sensory perception,GO:0050974,Child Behavior Disorders,MESH:D002653,1,Lead,0,
detection of mechanical stimulus involved in sensory perception,GO:0050974,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
detection of mechanical stimulus involved in sensory perception of pain,GO:0050966,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
detection of oxidative stress,GO:0070994,Child Behavior Disorders,MESH:D002653,11,bisphenol A|Carbamazepine|Chlorpromazine|Isoniazid|Lamotrigine|Lead|Manganese|Methylphenidate|Niacinamide|Phenobarbital|Valproic Acid,0,
detection of oxidative stress,GO:0070994,"Child Development Disorders, Pervasive",MESH:D002659,4,Methionine|Methylphenidate|Topiramate|Valproic Acid,0,
detection of oxidative stress,GO:0070994,Child Nutrition Disorders,MESH:D015362,3,Riboflavin|Thiamine|Vitamin A,0,
detection of oxidative stress,GO:0070994,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
detection of oxidative stress,GO:0070994,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
detection of oxidative stress,GO:0070994,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
detection of temperature stimulus involved in sensory perception of pain,GO:0050965,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
detection of visible light,GO:0009584,"CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION",OMIM:616939,0,,1,GPR88
determination of adult lifespan,GO:0008340,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
determination of adult lifespan,GO:0008340,Child Behavior Disorders,MESH:D002653,2,bisphenol A|methylmercuric chloride,0,
determination of adult lifespan,GO:0008340,Diffuse Cerebral Sclerosis of Schilder,MESH:D002549,0,,1,POLG
determination of adult lifespan,GO:0008340,"Hypercalciuria, childhood idiopathic",MESH:C536082,0,,1,KL
detoxification,GO:0098754,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
developmental growth,GO:0048589,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
developmental process,GO:0032502,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
developmental process involved in reproduction,GO:0003006,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
developmental process involved in reproduction,GO:0003006,"Hypophosphatasia, Childhood",MESH:C562440,0,,1,ALPL
developmental process involved in reproduction,GO:0003006,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
development of symbiont in host,GO:0044114,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
diacylglycerol metabolic process,GO:0046339,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
diakinesis,GO:0000241,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
diestrus,GO:0060207,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
diet induced thermogenesis,GO:0002024,Child Behavior Disorders,MESH:D002653,1,DDT,0,
digestive system process,GO:0022600,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
disaccharide metabolic process,GO:0005984,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
DNA amplification,GO:0006277,Child Nutrition Disorders,MESH:D015362,1,Mebendazole,0,
DNA biosynthetic process,GO:0071897,Child Behavior Disorders,MESH:D002653,3,bisphenol A|methylmercuric chloride|Phenobarbital,0,
DNA biosynthetic process,GO:0071897,Diffuse Cerebral Sclerosis of Schilder,MESH:D002549,0,,1,POLG
DNA catabolic process,GO:0006308,Child Behavior Disorders,MESH:D002653,1,Chlorpromazine,0,
DNA catabolic process,GO:0006308,Child Nutrition Disorders,MESH:D015362,2,Riboflavin|Vitamin A,0,
DNA catabolic process,GO:0006308,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,Child Behavior Disorders,MESH:D002653,4,bisphenol A|Carbamazepine|Isoniazid|Valproic Acid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Ascorbic Acid|lead acetate,0,
DNA endoreduplication,GO:0042023,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
DNA metabolic process,GO:0006259,Child Behavior Disorders,MESH:D002653,1,Isoniazid,0,
DNA metabolic process,GO:0006259,Diffuse Cerebral Sclerosis of Schilder,MESH:D002549,0,,1,POLG
DNA methylation,GO:0006306,Child Behavior Disorders,MESH:D002653,9,Amphetamine|bisphenol A|Cocaine|DDT|Haloperidol|Lead|Nitrogen Dioxide|Phenobarbital|Valproic Acid,0,
DNA methylation,GO:0006306,"Child Development Disorders, Pervasive",MESH:D002659,2,Methionine|Valproic Acid,0,
DNA methylation,GO:0006306,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
DNA methylation,GO:0006306,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
DNA methylation involved in gamete generation,GO:0043046,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
DNA methylation involved in gamete generation,GO:0043046,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
DNA methylation on cytosine,GO:0032776,Child Behavior Disorders,MESH:D002653,4,bisphenol A|DDT|Lead|methylmercuric chloride,0,
DNA methylation on cytosine,GO:0032776,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
DNA methylation on cytosine within a CG sequence,GO:0010424,Child Behavior Disorders,MESH:D002653,4,bisphenol A|DDT|Lead|Nitrogen Dioxide,0,
DNA methylation on cytosine within a CG sequence,GO:0010424,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
DNA methylation on cytosine within a CG sequence,GO:0010424,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
DNA methylation or demethylation,GO:0044728,Child Behavior Disorders,MESH:D002653,1,Lead,0,
DNA methylation or demethylation,GO:0044728,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
DNA modification,GO:0006304,Child Behavior Disorders,MESH:D002653,6,bisphenol A|DDT|Lithium|Lithium Carbonate|Pentachlorophenol|Valproic Acid,0,
DNA modification,GO:0006304,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
DNA modification,GO:0006304,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Ascorbic Acid|lead acetate,0,
DNA repair,GO:0006281,Child Behavior Disorders,MESH:D002653,1,Lead,0,
DNA repair,GO:0006281,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
DNA repair,GO:0006281,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
DNA replication,GO:0006260,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Phenobarbital,0,
DNA replication,GO:0006260,Diffuse Cerebral Sclerosis of Schilder,MESH:D002549,0,,1,POLG
DNA replication proofreading,GO:0045004,Diffuse Cerebral Sclerosis of Schilder,MESH:D002549,0,,1,POLG
DNA synthesis involved in DNA replication,GO:0090592,Child Behavior Disorders,MESH:D002653,1,Phenobarbital,0,
DNA-templated DNA replication,GO:0006261,Diffuse Cerebral Sclerosis of Schilder,MESH:D002549,0,,1,POLG
DNA-templated transcription termination,GO:0006353,Spinal Muscular Atrophies of Childhood,MESH:D014897,0,,2,SMN1|SMN2
dopamine biosynthetic process,GO:0042416,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Cocaine|Haloperidol,0,
dopamine biosynthetic process,GO:0042416,"Child Development Disorders, Pervasive",MESH:D002659,1,Topiramate,0,
dopamine biosynthetic process,GO:0042416,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
dopamine metabolic process,GO:0042417,Child Behavior Disorders,MESH:D002653,4,bisphenol A|Manganese|methylmercuric chloride|Valproic Acid,0,
dopamine metabolic process,GO:0042417,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
dopamine receptor signaling pathway,GO:0007212,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,DRD4
dopaminergic neuron differentiation,GO:0071542,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Methylphenidate,0,
dopaminergic neuron differentiation,GO:0071542,"Child Development Disorders, Pervasive",MESH:D002659,1,Methylphenidate,0,
dopaminergic neuron differentiation,GO:0071542,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
dopamine secretion,GO:0014046,Child Behavior Disorders,MESH:D002653,4,Amphetamine|Dextroamphetamine|Haloperidol|Methylphenidate,0,
dopamine secretion,GO:0014046,"Child Development Disorders, Pervasive",MESH:D002659,1,Methylphenidate,0,
"dopamine secretion, neurotransmission",GO:0061527,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
dopamine uptake,GO:0090494,Child Behavior Disorders,MESH:D002653,3,Amphetamine|bisphenol A|Cocaine,0,
dorsal/ventral pattern formation,GO:0009953,"Arthropathy, progressive pseudorheumatoid, of childhood",MESH:C535387,0,,1,CCN6
double-strand break repair via homologous recombination,GO:0000724,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
double-strand break repair via homologous recombination,GO:0000724,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
drinking behavior,GO:0042756,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Lead|Valproic Acid,0,
drinking behavior,GO:0042756,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
drinking behavior,GO:0042756,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
eating behavior,GO:0042755,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
eating behavior,GO:0042755,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
eclosion,GO:0007562,Child Behavior Disorders,MESH:D002653,1,methylmercuric chloride,0,
electron transport chain,GO:0022900,Child Behavior Disorders,MESH:D002653,1,Cocaine,0,
embryo development,GO:0009790,Child Behavior Disorders,MESH:D002653,3,bisphenol A|methylmercuric chloride|Valproic Acid,0,
embryo development,GO:0009790,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,1,MECP2
embryo development ending in birth or egg hatching,GO:0009792,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
embryo implantation,GO:0007566,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
embryonic body morphogenesis,GO:0010172,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
embryonic camera-type eye morphogenesis,GO:0048596,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
embryonic cleavage,GO:0040016,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
embryonic cleavage,GO:0040016,"Hypercalciuria, childhood idiopathic",MESH:C536082,0,,1,KL
embryonic digestive tract development,GO:0048566,Child Behavior Disorders,MESH:D002653,1,Isoniazid,0,
embryonic digit morphogenesis,GO:0042733,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
embryonic forelimb morphogenesis,GO:0035115,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
embryonic heart tube elongation,GO:0036306,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
embryonic hindlimb morphogenesis,GO:0035116,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
embryonic liver development,GO:1990402,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
embryonic organ development,GO:0048568,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MRTFB
embryonic placenta development,GO:0001892,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Carbon,0,
embryonic skeletal joint morphogenesis,GO:0060272,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
endocannabinoid signaling pathway,GO:0071926,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
endochondral ossification,GO:0001958,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
endochondral ossification,GO:0001958,"Hypophosphatasia, Childhood",MESH:C562440,0,,1,ALPL
endochondral ossification,GO:0001958,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
endocytosis,GO:0006897,Child Behavior Disorders,MESH:D002653,1,Prednisolone,0,
endoplasmic reticulum calcium ion homeostasis,GO:0032469,Child Behavior Disorders,MESH:D002653,2,Lead|methylmercuric chloride,0,
endoplasmic reticulum calcium ion homeostasis,GO:0032469,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
endoplasmic reticulum organization,GO:0007029,Child Behavior Disorders,MESH:D002653,2,Dextromethorphan|Lead,0,
endoplasmic reticulum organization,GO:0007029,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
endosomal lumen acidification,GO:0048388,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
endosomal transport,GO:0016197,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET",OMIM:617145,0,,1,SQSTM1
endosome organization,GO:0007032,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET",OMIM:617145,0,,1,SQSTM1
endothelial tube morphogenesis,GO:0061154,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
"energy coupled proton transmembrane transport, against electrochemical gradient",GO:0015988,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A2
energy derivation by oxidation of organic compounds,GO:0015980,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
energy homeostasis,GO:0097009,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET",OMIM:617145,0,,1,SQSTM1
energy reserve metabolic process,GO:0006112,"Hypercalciuria, childhood idiopathic",MESH:C536082,0,,1,KL
enteric nervous system development,GO:0048484,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
entry of bacterium into host cell,GO:0035635,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
eosinophil differentiation,GO:0030222,Child Behavior Disorders,MESH:D002653,1,Lead,0,
eosinophil differentiation,GO:0030222,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
eosinophil extravasation,GO:0072682,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
eosinophil migration,GO:0072677,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
epiboly,GO:0090504,Child Behavior Disorders,MESH:D002653,1,Pentachlorophenol,0,
epidermal growth factor receptor signaling pathway,GO:0007173,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
epigenetic regulation of gene expression,GO:0040029,Child Behavior Disorders,MESH:D002653,2,bisphenol A|DDT,0,
epigenetic regulation of gene expression,GO:0040029,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
epinephrine metabolic process,GO:0042414,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
epithelial cell-cell adhesion,GO:0090136,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
epithelial cell proliferation,GO:0050673,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
epithelial structure maintenance,GO:0010669,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
epithelial structure maintenance,GO:0010669,Child Nutrition Disorders,MESH:D015362,1,Cholecalciferol,0,
epithelial structure maintenance,GO:0010669,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
epithelial to mesenchymal transition,GO:0001837,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
ERK1 and ERK2 cascade,GO:0070371,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
ERK1 and ERK2 cascade,GO:0070371,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
erythrocyte development,GO:0048821,Child Behavior Disorders,MESH:D002653,1,Lead,0,
erythrocyte development,GO:0048821,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
erythrocyte homeostasis,GO:0034101,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
erythrocyte homeostasis,GO:0034101,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
erythromycin metabolic process,GO:1901113,Child Behavior Disorders,MESH:D002653,1,Phenobarbital,0,
erythromycin metabolic process,GO:1901113,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
establishment of cell polarity,GO:0030010,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
establishment of endothelial barrier,GO:0061028,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
establishment of endothelial blood-brain barrier,GO:0014045,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
establishment of endothelial blood-brain barrier,GO:0014045,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
establishment of endothelial intestinal barrier,GO:0090557,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Valproic Acid,0,
establishment of endothelial intestinal barrier,GO:0090557,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
establishment of protein localization to plasma membrane,GO:0061951,Child Behavior Disorders,MESH:D002653,4,Haloperidol|Imipramine|Prednisone|Thioridazine,0,
establishment of Sertoli cell barrier,GO:0097368,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
establishment of skin barrier,GO:0061436,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
establishment of spindle localization,GO:0051293,Spinal Muscular Atrophies of Childhood,MESH:D014897,0,,1,DYNC1H1
establishment or maintenance of transmembrane electrochemical gradient,GO:0010248,Alternating hemiplegia of childhood,MESH:C536589,0,,2,ATP1A2|ATP1A3
estradiol secretion,GO:0035938,Child Behavior Disorders,MESH:D002653,2,bisphenol A|DDT,0,
estrogen biosynthetic process,GO:0006703,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
estrogen biosynthetic process,GO:0006703,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
estrogen metabolic process,GO:0008210,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lamotrigine,0,
estrogen secretion,GO:0035937,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
estrogen secretion,GO:0035937,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
estrous cycle,GO:0044849,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Niacinamide,0,
estrous cycle phase,GO:0060206,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
estrus,GO:0060209,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
ether lipid biosynthetic process,GO:0008611,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
ether lipid biosynthetic process,GO:0008611,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
excitatory postsynaptic potential,GO:0060079,Child Behavior Disorders,MESH:D002653,6,Amphetamine|Carbamazepine|Cocaine|Haloperidol|Imipramine|Lamotrigine,0,
excitatory postsynaptic potential,GO:0060079,"Child Development Disorders, Pervasive",MESH:D002659,1,Topiramate,1,MECP2
exosomal secretion,GO:1990182,Child Behavior Disorders,MESH:D002653,1,Lead,0,
exosomal secretion,GO:1990182,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
exploration behavior,GO:0035640,Child Behavior Disorders,MESH:D002653,5,bisphenol A|Haloperidol|Lead|methylmercuric chloride|Valproic Acid,0,
exploration behavior,GO:0035640,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
exploration behavior,GO:0035640,Child Nutrition Disorders,MESH:D015362,1,Vitamin A,0,
exploration behavior,GO:0035640,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
extracellular exosome assembly,GO:0071971,Child Behavior Disorders,MESH:D002653,1,Lead,0,
extracellular exosome assembly,GO:0071971,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
extracellular matrix organization,GO:0030198,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
extrinsic apoptotic signaling pathway in absence of ligand,GO:0097192,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
eyelid development in camera-type eye,GO:0061029,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
eyelid development in camera-type eye,GO:0061029,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
fat cell differentiation,GO:0045444,Child Behavior Disorders,MESH:D002653,3,bisphenol A|DDT|Isoniazid,0,
fat cell differentiation,GO:0045444,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
fat cell proliferation,GO:0070341,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
fat pad development,GO:0060613,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Olanzapine,0,
fatty acid beta-oxidation,GO:0006635,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Olanzapine,0,
fatty acid biosynthetic process,GO:0006633,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Dextromethorphan,0,
fatty acid biosynthetic process,GO:0006633,"DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES",OMIM:617282,0,,1,MECR
fatty acid derivative metabolic process,GO:1901568,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Haloperidol,0,
fatty acid homeostasis,GO:0055089,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Dextromethorphan,0,
fatty acid homeostasis,GO:0055089,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
fatty acid metabolic process,GO:0006631,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Manganese,0,
fatty acid metabolic process,GO:0006631,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
fatty acid metabolic process,GO:0006631,"DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES",OMIM:617282,0,,1,MECR
fatty acid oxidation,GO:0019395,Child Behavior Disorders,MESH:D002653,1,Olanzapine,0,
fatty acid transport,GO:0015908,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
fear response,GO:0042596,Alternating hemiplegia of childhood,MESH:C536589,0,,2,ATP1A2|ATP1A3
fear response,GO:0042596,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,DRD4
feeding behavior,GO:0007631,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Lead|Valproic Acid,0,
feeding behavior,GO:0007631,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
feeding behavior,GO:0007631,Child Nutrition Disorders,MESH:D015362,1,Vitamin A,0,
feeding behavior,GO:0007631,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
female gonad development,GO:0008585,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
female mating behavior,GO:0060180,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
female pregnancy,GO:0007565,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
ferroptosis,GO:0097707,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
ferroptosis,GO:0097707,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
fertilization,GO:0009566,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Isoniazid,0,
fetal process involved in parturition,GO:0060138,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
fibroblast growth factor receptor signaling pathway,GO:0008543,"Hypercalciuria, childhood idiopathic",MESH:C536082,0,,1,KL
fibroblast migration,GO:0010761,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
filopodium assembly,GO:0046847,Child Behavior Disorders,MESH:D002653,2,Haloperidol|Manganese,0,
filopodium assembly,GO:0046847,"Child Development Disorders, Pervasive",MESH:D002659,1,Citalopram,0,
filopodium assembly,GO:0046847,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
flagellated sperm motility,GO:0030317,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
flagellated sperm motility,GO:0030317,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
flight,GO:0060361,Child Behavior Disorders,MESH:D002653,1,methylmercuric chloride,0,
flight involved in flight behavior,GO:0060362,Child Behavior Disorders,MESH:D002653,1,methylmercuric chloride,0,
focal adhesion assembly,GO:0048041,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
folate import across plasma membrane,GO:1904447,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
folate import across plasma membrane,GO:1904447,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
folic acid transport,GO:0015884,Child Nutrition Disorders,MESH:D015362,1,Cholecalciferol,0,
follicle-stimulating hormone secretion,GO:0046884,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
follicular fluid formation in ovarian follicle antrum,GO:0001548,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
forebrain development,GO:0030900,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MRTFB
formation of cytoplasmic translation initiation complex,GO:0001732,Child Behavior Disorders,MESH:D002653,1,methylmercuric chloride,0,
formation of peptidyl-cystine persulfide by sulphur transfer from H2S,GO:0044527,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
fructose biosynthetic process,GO:0046370,Child Behavior Disorders,MESH:D002653,1,DDT,0,
fructose metabolic process,GO:0006000,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
futile creatine cycle,GO:0140651,"Hypophosphatasia, Childhood",MESH:C562440,0,,1,ALPL
G0 to G1 transition,GO:0045023,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Manganese,0,
G0 to G1 transition,GO:0045023,Child Nutrition Disorders,MESH:D015362,1,Mebendazole,0,
G2/M transition of mitotic cell cycle,GO:0000086,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Manganese|methylmercuric chloride,0,
G2/M transition of mitotic cell cycle,GO:0000086,Child Nutrition Disorders,MESH:D015362,1,Mebendazole,0,
galactose metabolic process,GO:0006012,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
gamma-aminobutyric acid biosynthetic process,GO:0009449,"Child Development Disorders, Pervasive",MESH:D002659,1,Topiramate,0,
gamma-aminobutyric acid import,GO:0051939,Child Nutrition Disorders,MESH:D015362,1,Cholecalciferol,0,
gamma-aminobutyric acid metabolic process,GO:0009448,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
gamma-aminobutyric acid metabolic process,GO:0009448,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
gamma-aminobutyric acid signaling pathway,GO:0007214,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
gamma-aminobutyric acid signaling pathway,GO:0007214,Child Behavior Disorders,MESH:D002653,2,bisphenol A|methylmercuric chloride,0,
ganglion development,GO:0061548,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
gap junction assembly,GO:0016264,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
gap junction-mediated intercellular transport,GO:1990349,Child Behavior Disorders,MESH:D002653,2,bisphenol A|DDT,0,
gene expression,GO:0010467,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Carbon|Nitrogen Dioxide,0,
gene expression,GO:0010467,"Child Development Disorders, Pervasive",MESH:D002659,0,,2,MECP2|MRTFB
generation of neurons,GO:0048699,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
genomic imprinting,GO:0071514,Child Behavior Disorders,MESH:D002653,2,bisphenol A|DDT,0,
genomic imprinting,GO:0071514,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
germ cell development,GO:0007281,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
germ cell migration,GO:0008354,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
glandular epithelial cell differentiation,GO:0002067,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
glial cell activation,GO:0061900,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
glial cell differentiation,GO:0010001,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
glial cell proliferation,GO:0014009,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
globus pallidus development,GO:0021759,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
glomerular filtration,GO:0003094,Child Behavior Disorders,MESH:D002653,1,Lead,0,
glomerular filtration,GO:0003094,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
glucagon secretion,GO:0070091,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
glucarate biosynthetic process,GO:0019393,Child Behavior Disorders,MESH:D002653,1,DDT,0,
glucocorticoid metabolic process,GO:0008211,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
gluconeogenesis,GO:0006094,Child Behavior Disorders,MESH:D002653,4,bisphenol A|DDT|Phenobarbital|Prednisone,0,
glucose catabolic process,GO:0006007,Child Behavior Disorders,MESH:D002653,3,bisphenol A|DDT|Manganese,0,
glucose catabolic process,GO:0006007,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
glucose homeostasis,GO:0042593,Child Behavior Disorders,MESH:D002653,7,bisphenol A|Carbamazepine|DDT|Lead|methylmercuric chloride|Niacinamide|Nitrogen Dioxide,0,
glucose homeostasis,GO:0042593,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
glucose homeostasis,GO:0042593,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
glucose import,GO:0046323,Child Behavior Disorders,MESH:D002653,4,bisphenol A|DDT|Lead|Valproic Acid,0,
glucose import,GO:0046323,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
glucose import,GO:0046323,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
glucose import in response to insulin stimulus,GO:0044381,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
glucose metabolic process,GO:0006006,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Lead|Nitrogen Dioxide,0,
glucose metabolic process,GO:0006006,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
glucose transmembrane transport,GO:1904659,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
glucosylceramide metabolic process,GO:0006678,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
glutamate biosynthetic process,GO:0006537,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
glutamate biosynthetic process,GO:0006537,"Child Development Disorders, Pervasive",MESH:D002659,1,Topiramate,0,
glutamate metabolic process,GO:0006536,Child Behavior Disorders,MESH:D002653,3,bisphenol A|methylmercuric chloride|Valproic Acid,0,
glutamate metabolic process,GO:0006536,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
glutamine biosynthetic process,GO:0006542,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
glutamine metabolic process,GO:0006541,Child Behavior Disorders,MESH:D002653,2,bisphenol A|methylmercuric chloride,0,
glutamine metabolic process,GO:0006541,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
glutathione biosynthetic process,GO:0006750,Child Behavior Disorders,MESH:D002653,13,bisphenol A|Chlorpromazine|Cocaine|DDT|Isoniazid|Lead|Lithium Carbonate|Manganese|methylmercuric chloride|Niacinamide|Pentachlorophenol|Phenobarbital|Valproic Acid,0,
glutathione biosynthetic process,GO:0006750,"Child Development Disorders, Pervasive",MESH:D002659,3,Methionine|Topiramate|Valproic Acid,0,
glutathione biosynthetic process,GO:0006750,Child Nutrition Disorders,MESH:D015362,3,Cholecalciferol|Riboflavin|Thiamine,0,
glutathione biosynthetic process,GO:0006750,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
glutathione biosynthetic process,GO:0006750,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
glutathione biosynthetic process,GO:0006750,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
glutathione catabolic process,GO:0006751,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Risperidone,0,
glutathione catabolic process,GO:0006751,"Child Development Disorders, Pervasive",MESH:D002659,1,Risperidone,0,
glutathione catabolic process,GO:0006751,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
glutathione derivative biosynthetic process,GO:1901687,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
glutathione derivative biosynthetic process,GO:1901687,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
glutathione derivative biosynthetic process,GO:1901687,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
glutathione derivative biosynthetic process,GO:1901687,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Ascorbic Acid|lead acetate,0,
glutathione metabolic process,GO:0006749,Child Behavior Disorders,MESH:D002653,12,bisphenol A|Carbamazepine|Dextromethorphan|Imipramine|Isoniazid|Lead|Manganese|methylmercuric chloride|Niacinamide|Phenobarbital|Theophylline|Valproic Acid,0,
glutathione metabolic process,GO:0006749,"Child Development Disorders, Pervasive",MESH:D002659,3,Methionine|Topiramate|Valproic Acid,0,
glutathione metabolic process,GO:0006749,Child Nutrition Disorders,MESH:D015362,1,Cholecalciferol,0,
glutathione metabolic process,GO:0006749,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
glutathione metabolic process,GO:0006749,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
glycerol biosynthetic process,GO:0006114,Child Behavior Disorders,MESH:D002653,1,DDT,0,
glycerol metabolic process,GO:0006071,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
glycerophospholipid catabolic process,GO:0046475,Sick Building Syndrome,MESH:D018877,0,,1,PNPLA6
glycine biosynthetic process,GO:0006545,Child Behavior Disorders,MESH:D002653,2,bisphenol A|DDT,0,
glycogen biosynthetic process,GO:0005978,Child Behavior Disorders,MESH:D002653,1,Lithium Carbonate,0,
glycogen catabolic process,GO:0005980,Child Behavior Disorders,MESH:D002653,1,Theophylline,0,
glycogen metabolic process,GO:0005977,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Niacinamide,0,
glycogen metabolic process,GO:0005977,Child Nutrition Disorders,MESH:D015362,2,Cholecalciferol|Vitamin A,0,
glycogen metabolic process,GO:0005977,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
glycolate metabolic process,GO:0009441,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
glycolytic process,GO:0006096,Child Behavior Disorders,MESH:D002653,4,bisphenol A|DDT|Lead|methylmercuric chloride,0,
glycolytic process,GO:0006096,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
glycolytic process,GO:0006096,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
glycoprotein metabolic process,GO:0009100,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
glycoprotein metabolic process,GO:0009100,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
glycosphingolipid biosynthetic process,GO:0006688,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
glycosylation,GO:0070085,Child Behavior Disorders,MESH:D002653,1,Haloperidol,0,
Golgi organization,GO:0007030,Child Behavior Disorders,MESH:D002653,1,Dextromethorphan,0,
G protein-coupled receptor signaling pathway,GO:0007186,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,DRD4
G protein-coupled receptor signaling pathway,GO:0007186,"CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION",OMIM:616939,0,,1,GPR88
G protein-coupled serotonin receptor signaling pathway,GO:0098664,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,DRD4
gravitaxis,GO:0042332,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
grooming behavior,GO:0007625,Child Behavior Disorders,MESH:D002653,5,bisphenol A|Lead|Manganese|methylmercuric chloride|Valproic Acid,0,
grooming behavior,GO:0007625,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
grooming behavior,GO:0007625,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Ascorbic Acid|Lead,0,
growth,GO:0040007,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
growth hormone receptor signaling pathway via JAK-STAT,GO:0060397,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
growth involved in heart morphogenesis,GO:0003241,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
growth plate cartilage chondrocyte development,GO:0003431,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
growth plate cartilage chondrocyte proliferation,GO:0003419,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
growth plate cartilage development,GO:0003417,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
habituation,GO:0046959,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
habituation,GO:0046959,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
hair cell differentiation,GO:0035315,Child Behavior Disorders,MESH:D002653,1,methylmercuric chloride,0,
hatching,GO:0035188,Child Behavior Disorders,MESH:D002653,6,bisphenol A|Carbamazepine|Isoniazid|methylmercuric chloride|Pentachlorophenol|Valproic Acid,0,
hatching,GO:0035188,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
head development,GO:0060322,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Lead|Valproic Acid,0,
head development,GO:0060322,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
head development,GO:0060322,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
head morphogenesis,GO:0060323,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
heart contraction,GO:0060047,Child Behavior Disorders,MESH:D002653,5,bisphenol A|Carbon|Lead|Manganese|Nitrogen Dioxide,0,
heart contraction,GO:0060047,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
heart development,GO:0007507,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Manganese,0,
heart development,GO:0007507,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MRTFB
heart looping,GO:0001947,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
heart morphogenesis,GO:0003007,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MRTFB
heart morphogenesis,GO:0003007,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
heme metabolic process,GO:0042168,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Phenobarbital,0,
hemoglobin biosynthetic process,GO:0042541,Child Behavior Disorders,MESH:D002653,3,Lead|Lithium Carbonate|Nitrogen Dioxide,0,
hemoglobin biosynthetic process,GO:0042541,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
hemoglobin catabolic process,GO:0042540,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
hemoglobin metabolic process,GO:0020027,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
hemoglobin metabolic process,GO:0020027,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
hemopoiesis,GO:0030097,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
hemopoiesis,GO:0030097,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
hepaticobiliary system development,GO:0061008,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
hepatic stellate cell activation,GO:0035733,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
hepatic stellate cell activation,GO:0035733,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
hepatocyte differentiation,GO:0070365,Child Behavior Disorders,MESH:D002653,2,Niacinamide|Pentachlorophenol,0,
hepatocyte differentiation,GO:0070365,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
heterochromatin formation,GO:0031507,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
heterocycle metabolic process,GO:0046483,Child Behavior Disorders,MESH:D002653,1,Niacinamide,0,
heterocycle metabolic process,GO:0046483,Child Nutrition Disorders,MESH:D015362,1,Thiamine,0,
hippocampal interneuron differentiation,GO:0097410,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
hippocampus development,GO:0021766,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
hippocampus development,GO:0021766,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
histamine secretion,GO:0001821,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Dextromethorphan,0,
histamine secretion involved in inflammatory response,GO:0002441,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
histamine secretion mediated by immunoglobulin,GO:0097280,Child Behavior Disorders,MESH:D002653,4,Lithium|Methylphenidate|Prednisolone|Theophylline,0,
histamine secretion mediated by immunoglobulin,GO:0097280,"Child Development Disorders, Pervasive",MESH:D002659,1,Methylphenidate,0,
histone acetylation,GO:0016573,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
histone acetylation,GO:0016573,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
histone H3 acetylation,GO:0043966,Child Behavior Disorders,MESH:D002653,4,bisphenol A|methylmercuric chloride|Niacinamide|Valproic Acid,0,
histone H3 acetylation,GO:0043966,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
histone H3 acetylation,GO:0043966,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
histone H3 deacetylation,GO:0070932,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
histone H3 deacetylation,GO:0070932,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
histone H3-K14 acetylation,GO:0044154,Child Behavior Disorders,MESH:D002653,2,bisphenol A|methylmercuric chloride,0,
histone H3-K18 acetylation,GO:0043971,Child Behavior Disorders,MESH:D002653,2,Manganese|Phenobarbital,0,
histone H3-K27 acetylation,GO:0043974,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
histone H3-K27 trimethylation,GO:0098532,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Lead|methylmercuric chloride,0,
histone H3-K27 trimethylation,GO:0098532,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
histone H3-K27 trimethylation,GO:0098532,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
histone H3-K36 dimethylation,GO:0097676,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
histone H3-K36 dimethylation,GO:0097676,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
histone H3-K36 methylation,GO:0010452,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
histone H3-K36 trimethylation,GO:0097198,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
histone H3-K36 trimethylation,GO:0097198,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
histone H3-K4 dimethylation,GO:0044648,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
histone H3-K4 dimethylation,GO:0044648,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
histone H3-K4 methylation,GO:0051568,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
histone H3-K4 trimethylation,GO:0080182,Child Behavior Disorders,MESH:D002653,4,bisphenol A|DDT|Lead|Phenobarbital,0,
histone H3-K4 trimethylation,GO:0080182,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
histone H3-K56 acetylation,GO:0097043,Child Behavior Disorders,MESH:D002653,1,Niacinamide,0,
histone H3-K9 acetylation,GO:0043970,Child Behavior Disorders,MESH:D002653,4,bisphenol A|Lead|methylmercuric chloride|Niacinamide,0,
histone H3-K9 acetylation,GO:0043970,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
histone H3-K9 dimethylation,GO:0036123,Child Behavior Disorders,MESH:D002653,3,Amphetamine|bisphenol A|Lead,0,
histone H3-K9 dimethylation,GO:0036123,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
histone H3-K9 trimethylation,GO:0036124,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
histone H3-R2 methylation,GO:0034970,Child Behavior Disorders,MESH:D002653,1,Cocaine,0,
histone H4 acetylation,GO:0043967,Child Behavior Disorders,MESH:D002653,3,Amphetamine|bisphenol A|Valproic Acid,0,
histone H4 acetylation,GO:0043967,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
histone H4 acetylation,GO:0043967,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
histone H4 deacetylation,GO:0070933,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
histone H4 deacetylation,GO:0070933,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
histone H4-K12 acetylation,GO:0043983,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
histone H4-K12 acetylation,GO:0043983,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
histone H4-K8 acetylation,GO:0043982,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
histone methylation,GO:0016571,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
homeostasis of number of cells,GO:0048872,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
homeostasis of number of cells,GO:0048872,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
homeostasis of number of cells within a tissue,GO:0048873,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Manganese,0,
homocysteine metabolic process,GO:0050667,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
homocysteine metabolic process,GO:0050667,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
homocysteine metabolic process,GO:0050667,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
homologous chromosome pairing at meiosis,GO:0007129,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
homotypic cell-cell adhesion,GO:0034109,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
hormone metabolic process,GO:0042445,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
host-mediated regulation of intestinal microbiota composition,GO:0048874,Child Behavior Disorders,MESH:D002653,5,bisphenol A|Carbamazepine|Lead|Manganese|methylmercuric chloride,0,
host-mediated regulation of intestinal microbiota composition,GO:0048874,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
humoral immune response,GO:0006959,Child Behavior Disorders,MESH:D002653,1,Lead,0,
humoral immune response,GO:0006959,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
hydrogen peroxide biosynthetic process,GO:0050665,Child Behavior Disorders,MESH:D002653,4,bisphenol A|Lead|Manganese|Prednisolone,0,
hydrogen peroxide biosynthetic process,GO:0050665,Child Nutrition Disorders,MESH:D015362,1,Cholecalciferol,0,
hydrogen peroxide biosynthetic process,GO:0050665,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
hydrogen peroxide catabolic process,GO:0042744,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
hydrogen peroxide metabolic process,GO:0042743,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Manganese,0,
hydrogen peroxide metabolic process,GO:0042743,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
hydrogen sulfide biosynthetic process,GO:0070814,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
hydrogen sulfide metabolic process,GO:0070813,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
hypermethylation of CpG island,GO:0044027,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
hypomethylation of CpG island,GO:0044029,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Nitrogen Dioxide,0,
hypoxanthine metabolic process,GO:0046100,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
immune response,GO:0006955,Child Behavior Disorders,MESH:D002653,1,methylmercuric chloride,0,
immune system process,GO:0002376,Child Behavior Disorders,MESH:D002653,1,methylmercuric chloride,0,
immune system process,GO:0002376,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET",OMIM:617145,0,,1,SQSTM1
immunoglobulin production,GO:0002377,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Lead|Pentachlorophenol,0,
immunoglobulin production,GO:0002377,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
immunoglobulin production involved in immunoglobulin-mediated immune response,GO:0002381,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Manganese|Pentachlorophenol,0,
import across plasma membrane,GO:0098739,Child Behavior Disorders,MESH:D002653,1,Isoniazid,0,
import across plasma membrane,GO:0098739,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
import into cell,GO:0098657,Child Behavior Disorders,MESH:D002653,2,Chlorpromazine|Phenobarbital,0,
import into nucleus,GO:0051170,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
import into nucleus,GO:0051170,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
inflammatory response,GO:0006954,Child Behavior Disorders,MESH:D002653,6,bisphenol A|Carbon|Isoniazid|Lead|Prednisone|Valproic Acid,0,
inflammatory response,GO:0006954,"Child Development Disorders, Pervasive",MESH:D002659,2,Methionine|Valproic Acid,1,MECP2
inflammatory response,GO:0006954,Child Nutrition Disorders,MESH:D015362,1,Cholecalciferol,0,
inflammatory response,GO:0006954,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
inflammatory response to antigenic stimulus,GO:0002437,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
inhibin secretion,GO:0032334,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
inhibition of non-skeletal tissue mineralization,GO:0140928,"Hypophosphatasia, Childhood",MESH:C562440,0,,1,ALPL
inhibitory chemical synaptic transmission,GO:0098977,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
inhibitory postsynaptic potential,GO:0060080,Child Behavior Disorders,MESH:D002653,5,Amphetamine|Chlorpromazine|Cocaine|Haloperidol|Risperidone,0,
inhibitory postsynaptic potential,GO:0060080,"Child Development Disorders, Pervasive",MESH:D002659,2,Risperidone|Topiramate,1,DRD4
inhibitory postsynaptic potential,GO:0060080,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
inhibitory postsynaptic potential,GO:0060080,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
initiation of primordial ovarian follicle growth,GO:0001544,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
innate vocalization behavior,GO:0098582,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
inner ear development,GO:0048839,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
inner ear morphogenesis,GO:0042472,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
innervation,GO:0060384,Child Behavior Disorders,MESH:D002653,2,bisphenol A|methylmercuric chloride,0,
inorganic anion import across plasma membrane,GO:0098658,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
inorganic cation transmembrane transport,GO:0098662,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
inorganic ion homeostasis,GO:0098771,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
inorganic ion homeostasis,GO:0098771,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
inositol biosynthetic process,GO:0006021,Child Behavior Disorders,MESH:D002653,1,DDT,0,
inositol metabolic process,GO:0006020,Child Behavior Disorders,MESH:D002653,1,Lead,0,
inositol metabolic process,GO:0006020,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
inositol metabolic process,GO:0006020,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
insulin metabolic process,GO:1901142,Child Behavior Disorders,MESH:D002653,3,bisphenol A|DDT|Manganese,0,
insulin receptor signaling pathway,GO:0008286,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
insulin secretion,GO:0030073,Child Behavior Disorders,MESH:D002653,3,bisphenol A|methylmercuric chloride|Niacinamide,0,
interleukin-10 production,GO:0032613,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
interleukin-13 production,GO:0032616,Child Behavior Disorders,MESH:D002653,1,Lead,0,
interleukin-13 production,GO:0032616,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
interleukin-17 production,GO:0032620,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
interleukin-2 production,GO:0032623,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
interleukin-6 production,GO:0032635,Child Behavior Disorders,MESH:D002653,1,Nitrogen Dioxide,0,
inter-male aggressive behavior,GO:0002121,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
intestinal D-glucose absorption,GO:0001951,Child Behavior Disorders,MESH:D002653,1,Lead,0,
intestinal D-glucose absorption,GO:0001951,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
intestinal epithelial cell development,GO:0060576,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
intestinal epithelial structure maintenance,GO:0060729,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
intracellular distribution of mitochondria,GO:0048312,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
intracellular distribution of mitochondria,GO:0048312,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
intracellular estrogen receptor signaling pathway,GO:0030520,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
intracellular pH reduction,GO:0051452,Child Behavior Disorders,MESH:D002653,1,Theophylline,0,
intracellular signal transduction,GO:0035556,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET",OMIM:617145,0,,1,SQSTM1
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0070059,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
in utero embryonic development,GO:0001701,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MRTFB
iodide transport,GO:0015705,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
ionotropic glutamate receptor signaling pathway,GO:0035235,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
iron ion homeostasis,GO:0055072,Child Behavior Disorders,MESH:D002653,3,bisphenol A|Isoniazid|Valproic Acid,0,
iron ion homeostasis,GO:0055072,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
iron ion homeostasis,GO:0055072,Child Nutrition Disorders,MESH:D015362,2,Cholecalciferol|Vitamin A,0,
iron ion import across plasma membrane,GO:0098711,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
isocitrate metabolic process,GO:0006102,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
isoleucine biosynthetic process,GO:0009097,Child Behavior Disorders,MESH:D002653,3,bisphenol A|DDT|Phenobarbital,0,
JNK cascade,GO:0007254,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
keratinocyte differentiation,GO:0030216,Child Behavior Disorders,MESH:D002653,1,Carbon,0,
kidney development,GO:0001822,Child Behavior Disorders,MESH:D002653,1,methylmercuric chloride,0,
lactate biosynthetic process,GO:0019249,Child Behavior Disorders,MESH:D002653,5,bisphenol A|Chlorpromazine|Haloperidol|Isoniazid|Risperidone,0,
lactate biosynthetic process,GO:0019249,"Child Development Disorders, Pervasive",MESH:D002659,1,Risperidone,0,
lactate biosynthetic process,GO:0019249,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
lactate biosynthetic process,GO:0019249,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
lactate metabolic process,GO:0006089,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
lactate metabolic process,GO:0006089,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
lactate transport,GO:0015727,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
lactic acid secretion,GO:0046722,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
lamellipodium assembly,GO:0030032,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
lamellipodium morphogenesis,GO:0072673,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
larval development,GO:0002164,Child Behavior Disorders,MESH:D002653,3,bisphenol A|methylmercuric chloride|Valproic Acid,0,
larval development,GO:0002164,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
larval development,GO:0002164,Child Nutrition Disorders,MESH:D015362,1,Vitamin A,0,
larval heart development,GO:0007508,"HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT",OMIM:617384,0,,1,DNAJC12
larval locomotory behavior,GO:0008345,Child Behavior Disorders,MESH:D002653,3,bisphenol A|methylmercuric chloride|Valproic Acid,0,
larval locomotory behavior,GO:0008345,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
L-ascorbic acid biosynthetic process,GO:0019853,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
L-ascorbic acid metabolic process,GO:0019852,Alternating hemiplegia of childhood,MESH:C536589,0,,2,ATP1A2|ATP1A3
L-ascorbic acid metabolic process,GO:0019852,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
L-ascorbic acid transmembrane transport,GO:0015882,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
L-cystine transport,GO:0015811,Child Nutrition Disorders,MESH:D015362,1,Vitamin A,0,
lead ion transport,GO:0015692,Child Behavior Disorders,MESH:D002653,1,Lead,0,
lead ion transport,GO:0015692,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
learning,GO:0007612,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
learning,GO:0007612,Child Behavior Disorders,MESH:D002653,4,bisphenol A|Lead|Manganese|methylmercuric chloride,0,
learning,GO:0007612,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
learning,GO:0007612,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
learning or memory,GO:0007611,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
learning or memory,GO:0007611,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
leucine biosynthetic process,GO:0009098,Child Behavior Disorders,MESH:D002653,1,DDT,0,
leukocyte activation,GO:0045321,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
leukocyte chemotaxis,GO:0030595,Child Behavior Disorders,MESH:D002653,5,Chlorpromazine|Niacinamide|Phenobarbital|Prednisolone|Theophylline,0,
leukocyte chemotaxis,GO:0030595,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
leukocyte chemotaxis,GO:0030595,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
leukocyte degranulation,GO:0043299,Child Nutrition Disorders,MESH:D015362,1,Vitamin A,0,
leukocyte homeostasis,GO:0001776,Child Behavior Disorders,MESH:D002653,3,Lead|Lithium Carbonate|Nitrogen Dioxide,0,
leukocyte homeostasis,GO:0001776,Child Nutrition Disorders,MESH:D015362,1,Cholecalciferol,0,
leukocyte homeostasis,GO:0001776,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
leukocyte migration involved in immune response,GO:0002522,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
leukocyte migration involved in inflammatory response,GO:0002523,Child Behavior Disorders,MESH:D002653,8,bisphenol A|Haloperidol|Lead|methylmercuric chloride|Nitrogen Dioxide|Prednisolone|Risperidone|Valproic Acid,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Child Development Disorders, Pervasive",MESH:D002659,3,Methionine|Risperidone|Valproic Acid,0,
leukocyte migration involved in inflammatory response,GO:0002523,Child Nutrition Disorders,MESH:D015362,2,Cholecalciferol|Vitamin A,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
leukotriene biosynthetic process,GO:0019370,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
Leydig cell differentiation,GO:0033327,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lithium,0,
Leydig cell differentiation,GO:0033327,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
Leydig cell proliferation,GO:0160024,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
L-glutamate import,GO:0051938,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
L-glutamate import,GO:0051938,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
L-glutamate import across plasma membrane,GO:0098712,Child Nutrition Disorders,MESH:D015362,1,Cholecalciferol,0,
limb bud formation,GO:0060174,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
limb morphogenesis,GO:0035108,Osteoarthritis with Mild Chondrodysplasia,MESH:C565740,0,,1,COL2A1
linoleic acid metabolic process,GO:0043651,Child Behavior Disorders,MESH:D002653,1,DDT,0,
lipid biosynthetic process,GO:0008610,Child Behavior Disorders,MESH:D002653,5,bisphenol A|Chlorpromazine|Isoniazid|Manganese|Valproic Acid,0,
lipid biosynthetic process,GO:0008610,"Child Development Disorders, Pervasive",MESH:D002659,3,Methionine|Topiramate|Valproic Acid,0,
lipid biosynthetic process,GO:0008610,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
lipid biosynthetic process,GO:0008610,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
lipid catabolic process,GO:0016042,Child Behavior Disorders,MESH:D002653,15,bisphenol A|Cocaine|Dextroamphetamine|Dextromethorphan|Isoniazid|Lead|Lithium|Lithium Carbonate|Manganese|methylmercuric chloride|Niacinamide|Phenobarbital|Prednisolone|Theophylline|Valproic Acid,0,
lipid catabolic process,GO:0016042,"Child Development Disorders, Pervasive",MESH:D002659,3,Methionine|Topiramate|Valproic Acid,0,
lipid catabolic process,GO:0016042,Child Nutrition Disorders,MESH:D015362,2,Cholecalciferol|Thiamine,0,
lipid catabolic process,GO:0016042,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
lipid catabolic process,GO:0016042,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
lipid catabolic process,GO:0016042,Sick Building Syndrome,MESH:D018877,0,,1,PNPLA6
lipid droplet formation,GO:0140042,Child Behavior Disorders,MESH:D002653,6,bisphenol A|Isoniazid|Niacinamide|Olanzapine|Prednisolone|Valproic Acid,0,
lipid droplet formation,GO:0140042,"Child Development Disorders, Pervasive",MESH:D002659,2,Methionine|Valproic Acid,0,
lipid droplet formation,GO:0140042,Child Nutrition Disorders,MESH:D015362,1,Cholecalciferol,0,
lipid droplet formation,GO:0140042,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Ascorbic Acid|lead acetate,0,
lipid droplet organization,GO:0034389,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
lipid droplet organization,GO:0034389,Child Nutrition Disorders,MESH:D015362,1,Vitamin A,0,
lipid homeostasis,GO:0055088,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
lipid homeostasis,GO:0055088,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
lipid homeostasis,GO:0055088,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
lipid import into cell,GO:0140354,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
lipid metabolic process,GO:0006629,Child Behavior Disorders,MESH:D002653,7,bisphenol A|Chlorpromazine|Isoniazid|Lead|methylmercuric chloride|Prednisone|Valproic Acid,0,
lipid metabolic process,GO:0006629,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
lipid metabolic process,GO:0006629,"DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES",OMIM:617282,0,,1,MECR
lipid metabolic process,GO:0006629,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
lipid metabolic process,GO:0006629,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
lipid metabolic process,GO:0006629,Sick Building Syndrome,MESH:D018877,0,,1,PNPLA6
lipid oxidation,GO:0034440,Child Behavior Disorders,MESH:D002653,11,bisphenol A|Carbamazepine|Haloperidol|Imipramine|Isoniazid|Lead|Lithium Carbonate|methylmercuric chloride|Prednisolone|Theophylline|Valproic Acid,0,
lipid oxidation,GO:0034440,"Child Development Disorders, Pervasive",MESH:D002659,2,Methionine|Valproic Acid,0,
lipid oxidation,GO:0034440,Child Nutrition Disorders,MESH:D015362,2,Cholecalciferol|Thiamine,0,
lipid oxidation,GO:0034440,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
lipopolysaccharide metabolic process,GO:0008653,Child Nutrition Disorders,MESH:D015362,1,Cholecalciferol,0,
lipoprotein biosynthetic process,GO:0042158,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
lipoprotein lipid oxidation,GO:0034439,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
lipoprotein metabolic process,GO:0042157,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
liver development,GO:0001889,Child Behavior Disorders,MESH:D002653,3,Carbamazepine|Manganese|Prednisone,0,
liver development,GO:0001889,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MRTFB
locomotion,GO:0040011,Alternating hemiplegia of childhood,MESH:C536589,0,,2,ATP1A2|ATP1A3
locomotion,GO:0040011,Child Behavior Disorders,MESH:D002653,4,Amphetamine|bisphenol A|Haloperidol|Manganese,0,
locomotion involved in locomotory behavior,GO:0031987,Child Behavior Disorders,MESH:D002653,15,Amphetamine|bisphenol A|Cocaine|Dextroamphetamine|Dextromethorphan|Haloperidol|Isoniazid|Lead|Lithium|Manganese|methylmercuric chloride|Methylphenidate|Olanzapine|Risperidone|Valproic Acid,0,
locomotion involved in locomotory behavior,GO:0031987,"Child Development Disorders, Pervasive",MESH:D002659,3,Methylphenidate|Risperidone|Valproic Acid,0,
locomotion involved in locomotory behavior,GO:0031987,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
locomotion involved in locomotory behavior,GO:0031987,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
locomotory behavior,GO:0007626,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
locomotory behavior,GO:0007626,Child Behavior Disorders,MESH:D002653,8,bisphenol A|Cocaine|Haloperidol|Lead|Manganese|Methylphenidate|Prednisolone|Valproic Acid,0,
locomotory behavior,GO:0007626,"Child Development Disorders, Pervasive",MESH:D002659,2,Methylphenidate|Valproic Acid,1,MECP2
locomotory behavior,GO:0007626,Child Nutrition Disorders,MESH:D015362,1,Vitamin A,0,
locomotory behavior,GO:0007626,"CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION",OMIM:616939,0,,1,GPR88
locomotory behavior,GO:0007626,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
locomotory behavior,GO:0007626,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET",OMIM:617145,0,,1,SQSTM1
locomotory exploration behavior,GO:0035641,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A2
locomotory exploration behavior,GO:0035641,Child Behavior Disorders,MESH:D002653,2,bisphenol A|methylmercuric chloride,0,
locomotory exploration behavior,GO:0035641,"Child Development Disorders, Pervasive",MESH:D002659,1,Topiramate,0,
locus ceruleus development,GO:0021703,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
long-term memory,GO:0007616,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
long-term synaptic depression,GO:0060292,Child Behavior Disorders,MESH:D002653,2,Amphetamine|bisphenol A,0,
long-term synaptic potentiation,GO:0060291,Child Behavior Disorders,MESH:D002653,2,Amphetamine|bisphenol A,0,
long-term synaptic potentiation,GO:0060291,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
L-phenylalanine biosynthetic process,GO:0009094,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
L-phenylalanine metabolic process,GO:0006558,Child Behavior Disorders,MESH:D002653,1,Nitrogen Dioxide,0,
lung alveolus development,GO:0048286,"Child Development Disorders, Pervasive",MESH:D002659,0,,1,MECP2
lung development,GO:0030324,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
luteinization,GO:0001553,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
luteinizing hormone secretion,GO:0032275,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
lymphocyte activation,GO:0046649,Child Behavior Disorders,MESH:D002653,2,Phenobarbital|Theophylline,0,
lymphocyte activation,GO:0046649,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
lymphocyte homeostasis,GO:0002260,Child Behavior Disorders,MESH:D002653,1,Lithium Carbonate,0,
lymphocyte homeostasis,GO:0002260,"Schizophrenia, Childhood",MESH:D012561,1,Clozapine,0,
lymphocyte mediated immunity,GO:0002449,Child Behavior Disorders,MESH:D002653,1,Lead,0,
lymphocyte mediated immunity,GO:0002449,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
lymphocyte migration,GO:0072676,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
lysine biosynthetic process,GO:0009085,Child Behavior Disorders,MESH:D002653,3,bisphenol A|DDT|Phenobarbital,0,
lysine catabolic process,GO:0006554,Child Behavior Disorders,MESH:D002653,1,methylmercuric chloride,0,
lysosomal lumen acidification,GO:0007042,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
lysosomal membrane organization,GO:0097212,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
lysosomal protein catabolic process,GO:1905146,Child Behavior Disorders,MESH:D002653,1,methylmercuric chloride,0,
macroautophagy,GO:0016236,Child Behavior Disorders,MESH:D002653,1,Niacinamide,0,
macroautophagy,GO:0016236,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET",OMIM:617145,0,,1,SQSTM1
macrophage activation,GO:0042116,Child Behavior Disorders,MESH:D002653,4,bisphenol A|Cocaine|methylmercuric chloride|Valproic Acid,0,
macrophage activation,GO:0042116,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
macrophage derived foam cell differentiation,GO:0010742,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
macrophage homeostasis,GO:0061519,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
macrophage migration,GO:1905517,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Isoniazid,0,
macrophage migration,GO:1905517,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
maintenance of blood-brain barrier,GO:0035633,Child Behavior Disorders,MESH:D002653,1,Lead,0,
maintenance of blood-brain barrier,GO:0035633,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
maintenance of cell number,GO:0098727,Child Behavior Disorders,MESH:D002653,1,Lead,0,
maintenance of cell number,GO:0098727,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
maintenance of synapse structure,GO:0099558,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
male courtship behavior,GO:0008049,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
"male courtship behavior, orientation prior to leg tapping and wing vibration",GO:0016543,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
"male courtship behavior, proboscis-mediated licking",GO:0016546,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
"male courtship behavior, tapping to detect pheromone",GO:0016544,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
"male courtship behavior, veined wing vibration",GO:0016545,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
male germ cell proliferation,GO:0002176,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
male germ-line stem cell population maintenance,GO:0036098,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
male gonad development,GO:0008584,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
male gonad development,GO:0008584,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
male mating behavior,GO:0060179,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
male meiosis I,GO:0007141,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
male meiotic nuclear division,GO:0007140,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
mammary duct terminal end bud growth,GO:0060763,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
mammary gland development,GO:0030879,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Olanzapine,0,
mammary gland development,GO:0030879,"Child Development Disorders, Pervasive",MESH:D002659,1,Aripiprazole,0,
mammary gland duct morphogenesis,GO:0060603,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
mammary gland morphogenesis,GO:0060443,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
manganese ion export across plasma membrane,GO:0140048,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
manganese ion homeostasis,GO:0055071,Child Behavior Disorders,MESH:D002653,1,Manganese,0,
manganese ion transmembrane transport,GO:0071421,Child Behavior Disorders,MESH:D002653,2,Imipramine|Manganese,0,
manganese ion transport,GO:0006828,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
MAPK cascade,GO:0000165,Child Behavior Disorders,MESH:D002653,1,Cocaine,0,
mast cell degranulation,GO:0043303,Child Behavior Disorders,MESH:D002653,2,Chlorpromazine|Dextromethorphan,0,
maternal placenta development,GO:0001893,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
maternal placenta development,GO:0001893,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
maternal process involved in female pregnancy,GO:0060135,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
maternal process involved in female pregnancy,GO:0060135,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
maternal process involved in parturition,GO:0060137,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
mating,GO:0007618,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
meiotic anaphase I,GO:0007133,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
meiotic cell cycle,GO:0051321,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
meiotic cell cycle checkpoint signaling,GO:0033313,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
meiotic cell cycle process,GO:1903046,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
meiotic cell cycle process involved in oocyte maturation,GO:1903537,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Isoniazid,0,
meiotic chromosome separation,GO:0051307,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
meiotic DNA double-strand break formation,GO:0042138,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
meiotic DNA repair synthesis,GO:0000711,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
meiotic metaphase II,GO:0007137,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
meiotic metaphase II plate congression,GO:0043061,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
meiotic prophase I,GO:0007128,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
meiotic recombination checkpoint signaling,GO:0051598,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
meiotic spindle organization,GO:0000212,Child Behavior Disorders,MESH:D002653,1,Isoniazid,0,
meiotic telophase I,GO:0007134,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
melanin biosynthetic process,GO:0042438,Child Behavior Disorders,MESH:D002653,1,Theophylline,0,
melatonin biosynthetic process,GO:0030187,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
melatonin metabolic process,GO:0030186,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
membrane depolarization,GO:0051899,Alternating hemiplegia of childhood,MESH:C536589,0,,2,ATP1A2|ATP1A3
membrane depolarization,GO:0051899,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
membrane depolarization during cardiac muscle cell action potential,GO:0086012,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A2
membrane hyperpolarization,GO:0060081,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
membrane hyperpolarization,GO:0060081,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
membrane lipid catabolic process,GO:0046466,Child Behavior Disorders,MESH:D002653,19,bisphenol A|Carbon|Chlorpromazine|Cocaine|Dextroamphetamine|Haloperidol|Isoniazid|Lead|Lithium|Lithium Carbonate|Manganese|methylmercuric chloride|Nitrogen Dioxide|Olanzapine|Phenobarbital|Risperidone|Theophylline|Thioridazine|Valproic Acid,0,
membrane lipid catabolic process,GO:0046466,"Child Development Disorders, Pervasive",MESH:D002659,4,Methionine|Risperidone|Topiramate|Valproic Acid,0,
membrane lipid catabolic process,GO:0046466,Child Nutrition Disorders,MESH:D015362,2,Thiamine|Vitamin A,0,
membrane lipid catabolic process,GO:0046466,"Hypercalciuria, childhood idiopathic",MESH:C536082,1,Ketoconazole,0,
membrane lipid catabolic process,GO:0046466,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
membrane organization,GO:0061024,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
membrane repolarization,GO:0086009,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A2
membrane repolarization during ventricular cardiac muscle cell action potential,GO:0098915,Child Behavior Disorders,MESH:D002653,1,Fluvoxamine,0,
memory,GO:0007613,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
memory,GO:0007613,Child Behavior Disorders,MESH:D002653,8,bisphenol A|Carbon|DDT|Lead|Lithium|Manganese|methylmercuric chloride|Risperidone,0,
memory,GO:0007613,"Child Development Disorders, Pervasive",MESH:D002659,1,Risperidone,1,MECP2
memory,GO:0007613,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
menarche,GO:0042696,Child Behavior Disorders,MESH:D002653,2,DDT|Lead,0,
menarche,GO:0042696,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
menopause,GO:0042697,Child Behavior Disorders,MESH:D002653,1,Lead,0,
menopause,GO:0042697,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
mercury ion transport,GO:0015694,Child Behavior Disorders,MESH:D002653,1,methylmercuric chloride,0,
mesenchymal cell differentiation involved in kidney development,GO:0072161,Child Behavior Disorders,MESH:D002653,1,Lithium,0,
metabolic process,GO:0008152,Alternating hemiplegia of childhood,MESH:C536589,0,,1,ATP1A3
metabolic process,GO:0008152,Child Behavior Disorders,MESH:D002653,4,bisphenol A|Lead|Niacinamide|Pyridoxine,0,
metabolic process,GO:0008152,Child Nutrition Disorders,MESH:D015362,1,Pyridoxine,0,
metabolic process,GO:0008152,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
metal ion homeostasis,GO:0055065,Child Behavior Disorders,MESH:D002653,3,Lead|Lithium|Manganese,0,
metal ion homeostasis,GO:0055065,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
metal ion transport,GO:0030001,Child Behavior Disorders,MESH:D002653,1,Lead,0,
metal ion transport,GO:0030001,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
metamorphosis,GO:0007552,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
metestrus,GO:0060210,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
methionine biosynthetic process,GO:0009086,Child Behavior Disorders,MESH:D002653,1,DDT,0,
methionine metabolic process,GO:0006555,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
methylation,GO:0032259,"MONONEUROPATHY OF THE MEDIAN NERVE, MILD",OMIM:613353,0,,1,SH3TC2
microglia development,GO:0014005,Child Behavior Disorders,MESH:D002653,1,methylmercuric chloride,0,
microglial cell activation,GO:0001774,Child Behavior Disorders,MESH:D002653,2,Lead|Manganese,0,
microglial cell activation,GO:0001774,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
microglial cell proliferation,GO:0061518,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Valproic Acid,0,
microglial cell proliferation,GO:0061518,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
micronucleus organization,GO:0032125,Child Behavior Disorders,MESH:D002653,4,bisphenol A|Carbamazepine|Pentachlorophenol|Phenobarbital,0,
micronucleus organization,GO:0032125,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
micronucleus organization,GO:0032125,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Ascorbic Acid|lead acetate,0,
microtubule anchoring at centrosome,GO:0034454,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
microtubule-based movement,GO:0007018,Spinal Muscular Atrophies of Childhood,MESH:D014897,0,,1,DYNC1H1
microtubule cytoskeleton organization,GO:0000226,Child Behavior Disorders,MESH:D002653,1,Valproic Acid,0,
microtubule cytoskeleton organization,GO:0000226,"Child Development Disorders, Pervasive",MESH:D002659,1,Valproic Acid,0,
microtubule depolymerization,GO:0007019,Spinal Muscular Atrophies of Childhood,MESH:D014897,0,,1,SMN1
mineralocorticoid receptor signaling pathway,GO:0031959,Child Behavior Disorders,MESH:D002653,1,DDT,0,
mini excitatory postsynaptic potential,GO:0098816,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,lead acetate,0,
mitochondrial ATP synthesis coupled electron transport,GO:0042775,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
mitochondrial ATP synthesis coupled electron transport,GO:0042775,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
mitochondrial calcium ion homeostasis,GO:0051560,Child Behavior Disorders,MESH:D002653,3,Cocaine|Lead|methylmercuric chloride,0,
mitochondrial calcium ion homeostasis,GO:0051560,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
mitochondrial calcium ion homeostasis,GO:0051560,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
mitochondrial depolarization,GO:0051882,Child Behavior Disorders,MESH:D002653,5,bisphenol A|DDT|Lead|Manganese|Risperidone,0,
mitochondrial depolarization,GO:0051882,"Child Development Disorders, Pervasive",MESH:D002659,1,Risperidone,0,
mitochondrial depolarization,GO:0051882,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,3,Ascorbic Acid|Lead|lead acetate,0,
mitochondrial DNA metabolic process,GO:0032042,Child Behavior Disorders,MESH:D002653,2,Lead|Nitrogen Dioxide,0,
mitochondrial DNA metabolic process,GO:0032042,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Lead,0,
mitochondrial DNA replication,GO:0006264,Child Behavior Disorders,MESH:D002653,2,bisphenol A|Lead,0,
mitochondrial DNA replication,GO:0006264,Diffuse Cerebral Sclerosis of Schilder,MESH:D002549,0,,1,POLG
mitochondrial DNA replication,GO:0006264,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,2,Lead|lead acetate,0,
"mitochondrial electron transport, cytochrome c to oxygen",GO:0006123,Child Behavior Disorders,MESH:D002653,1,bisphenol A,0,
"mitochondrial electron transport, cytochrome c to oxygen",GO:0006123,"Child Development Disorders, Pervasive",MESH:D002659,1,Methionine,0,
"mitochondrial electron transport, cytochrome c to oxygen",GO:0006123,"Lead Poisoning, Nervous System, Childhood",MESH:D020264,1,Ascorbic Acid,0,
